Upload
others
View
5
Download
0
Embed Size (px)
Citation preview
A Report of Minor Research Project
EFFICACY OF MICROENCAPSULATION ON
SYNBIOTIC YOGURT PRODUCTION
Ms. SMITHA MATHEWS
(1939-MRP/14-15/KLMG034/UGC-SWRO)
Assistant Professor in Microbiology
Department of Zoology
Assumption Autonomous College
Changanacherry, Kottayam, Kerala, 686101
Submitted to
University Grants Commission
New Delhi
May 2017
ACKNOWLEDGEMENTS
The present study was supported by the University grants commission of India
under the grant No:1939-MRP/14-15/KLMG034/UGC-SWRO.
I would like to express my sincere gratitude and profound appreciation to
University Grants Commission (UGC), New Delhi for providing financial support for this
research.
I would like to express my sincere thanks to Dr Sr Amala SH, Principal,
Assumption College, Changanacherry for her inspiration, constant support and for
providing necessary lab facilities for carrying out this work.
I wish to thank Ms. Tessy Jose, HOD, Department of Zoology, Assumption College,
Changanacherry and my colleagues for their constant encouragement and support
throughout the period of my work.
I express my gratitude to Dr. Jickcy Isac, Department of Mathematics, Assumption
College, Changanacherry for carrying out my statistical work.
I deeply express my gratitude to my parents and family members for their constant
encouragement, valuable support and understanding.
Above all I thank God Almighty for his grace and blessings....
Smitha Mathews
CONTENTS
Abstract 1
1. Introduction 2
1.1 Probiotics and Prebiotics 2
1.2 Synbiotics 4
1.3 Viability of Probiotic organisms 4
1.4 Microencapsulation of Probiotics 5
1.5 Scope of present investigation 8
1.6 Objectives of the present investigation 9
2. Review of Literature 10
2.1 Yogurt 10
2.2 Definition of probiotics 11
2.3. Characteristics of lactobacillus 12
2.3.1. Lactobacillus acidophilus 12
2.3.2. Lactobacillus casei 13
2.4. Regulations and safety of probiotics in manufacture 13
2.5. Prebiotics 14
2.5.1. Inulin 15
2.5.2. Lactulose 16
2.6. Factors affecting the growth and survival of Lactobacillus 17
2.7. Effect of prebiotics on probiotic growth and survival. 18
2.8. Microencapsulation Technique 19
3. Materials and Methods 23
3.1 Materials 23
3.2 Methodology 24
3.2.1 Preparation of cell suspension 24
3.2.2 Production of Probiotic yogurt 24
3.2. a. Determination of pH 25
3.2. b. Determination of titratable acidity 25
3.2. c. Enumeration of L. acidophilus and L.casei in yogurt 25
3.2. d. Determination of Syneresis 25
3.3. Production of Synbiotic yogurt 26
3.3.a. Physicochemical and Microbial analysis of Synbiotic yogurt 26
3.4 Microencapsulation of Probiotic Cultures 26
3.4.1 Preparation of alginate microcapsules 27
3.4.2 Preparation of simulated gastric and intestinal juices
and inoculation of cells 28
3.4.3 In vitro release studies (GIT) 29
3.4.4 Release of entrapped bacteria 29
3.5. Co-encapsulated synbiotic yogurt Production 29
4. Results and Discussion 31
4.1 Preparation of cell suspension 31
4.2 Production of Probiotic yogurt 31
4.2.a. pH of Probiotic yogurt 31
4.2.b. Acidity (% Lactic acid) Probiotic yogurt 32
4.2.c. Bacterial counts of Probiotic yogurt 33
4.2.d. Syneresis of Probiotic yogurt 33
4.3 Synbiotic yogurt Production 34
4.3.a. pH of Synbiotic yogurt during storage 34
4.3.b. Acidity of Synbiotic yogurt during storage 35
4.3.c. Viability of Synbiotic yogurt during storage 36
4.3.d. syneresis of Synbiotic yogurt during storage 39
4.4. Microencapsulation of Probiotic yogurt 40
4.4.a. In vitro release studies of L.acidophilus and L. casei
from the microcapsules 40
4.4.b. Survival of free and microencapsulated probiotics
in simulated gastric juice 41
4.4.c Survival of free and microencapsulated probiotics
in simulated intestinal juice 43
4.5. Co-encapsulated synbiotic yogurt 44
4.5.a. pH changes during storage 45
4.5.b. Producing acidity during storage 46
4.5.c. Syneresis on storage 48
4.5.d. Viability of Lactobacillus strains grown in synbiotic yogurt 50
4.5.d.I. Survival of free and microencapsulated
synbiotic L. acidophilus in Yogurt during storage 50
4.5.d.II. Survival of free and microencapsulated
synbiotic L. casei in Yogurt during storage 51
5. Conclusion 56
6. Bibliography 58
1
ABSTRACT
Due to the perceived health benefits of probiotics, there has been an increased use
in different health based products. The viability of probiotic cells is of paramount
importance because to have their beneficial effects on the health, they must stay alive until
they reach their site of action. There are some problems pertaining to the survivability of
probiotic bacteria in dairy foods. This has encouraged developing different innovative
methods to improve the probiotic cells viability in the product incorporated. The objective
of the present study is to prepare probiotic, synbiotic and microencapsulated yogurt.
Physicochemical and microbiological properties of probiotic and synbiotic yogurt were
evaluated in the first day and thereafter every 7 days interval for 28 days of storage at 40C.
During cold storage, pH, and probiotic bacterial count decreased, while acidity and
syneresis were increased in Probiotic yogurt prepared with both organisms. Neither Inulin
nor Lactulose had significant effect on physicochemical changes (except pH) and probiotic
bacterial survival of L.acidophilus. There was a significant decrease (p<0.05) in pH of
synbiotic yogurt with inulin and lactulose. For L.casei, both prebiotics had significantly
reduced pH and increased acidity, and found to have some effect on viability of probiotic
bacteria, but inulin produced least change in syneresis.
Microencapsulation of probiotics is one of the approaches which is currently
receiving considerable attention. Here an attempt was made to determine the efficacy of
microcapsules prepared by alginate and gelatin coated alginate along with prebiotic
(lactulose or inulin) to give better protection in gastrointestinal tract and during
refrigerated storage of yogurt for 28 days. Probiotic Lactobacilli (Lactobacillus
acidophilus and Lactobacillus casei) with inulin and lactulose as prebiotics were
encapsulated in alginate and alginate –gelatin beads and to determine the effect of inulin
and Lactulose as well as microencapsulation on the physicochemical (pH, acidity, level of
syneresis) and microbiological (probiotic bacterial count) properties of synbiotic yogurt.
For both probiotics, alginate- gelatin along with prebiotic was found to give better
protection in simulated gastric juice (SGJ) and better release in gastro-intestinal
fluid(SIF). Further free cells were very susceptible to SGJ and SIF. Alginate-gelatin and
alginate microcapsules with lactulose was most effective in protecting L.acidophilus and
L.casei from simulated intestinal juice with an encapsulation efficiency of 97.38 % and
85.9 % respectively. Microencapsulated synbiotic were also used for production of yogurt.
The results showed that alginate–gelatin with inulin showed significant (p<0.05) effect on
least change in pH, acidity and syneresis and increase in bacterial count of L.acidophilus,
while alginate–gelatin with lactulose showed significant (p<0.05) effect on least change in
physicochemical and microbiological properties of L.casei. The final results showed that
L.casei had a higher viability than the level of the therapeutic minimum (>107 CFU/g)
during 28 days of storage in all the treatment while for L.acidophilus, only inulin
encapsulated in alginate–gelatin maintained the count above this limit. So co-
encapsulation of synbiotics can be used to enhance and improve the physicochemical
properties and viability of probiotic bacteria during processing and also in gastrointestinal
tract.
2
Chapter 1
INTRODUCTION
1.1 Probiotics and Prebiotics
In recent years, probiotics showed the increasing attention on its application for
improving the intestinal microbial balance of the human and animal, which was defined
as ‘‘living microorganisms” (Adhikari et al., 2000; Chandramouli et al., 2004;
FAO/WHO, 2006; Pedroso et al., 2012). Fuller (1989) has redefined a probiotic as ‘a live
microbial feed supplement which beneficially affects the host animal by improving its
intestinal microbial balance’. Lactobacillus acidophilus is frequently used in food
products, which have been reported to suppress the pathogens growth, improve lactose
utilization and stabilize the digestive system (Ouwehand et al., 1998; Kopp-Hoolihan,
2001; Kaur et al., 2002; Kim et al., 2008).
A prebiotic is a nondigestible food ingredient that beneficially affects the host by
selectively stimulating the growth and/or activity of one or a limited number of bacteria in
the colon, and thus improves host health (Gibson & Roberfroid, 1995). The majority of
simple sugars and oligosaccharides ingested and digested by humans are absorbed in the
small intestine (Bond et al., 1980). However some prebiotic such as lactulose, raffinose,
stachyose and fructooligosaccharides (such as oligofructose or inulin) are able to reach the
colon intact (Roberfroid et al., 1993). Prebiotics have been selectively manufactured to
contain several or all of the following attributes; active at low dosages, varying viscosity,
lack of side effects, varying sweetness, control of micro flora modulation, persistence
through the colon, good storage and processing stability and inhibition of pathogen
adhesion. Established and possible effects of prebiotics include nondigestibility and low
3
energy value, stool bulking effect and modulation of the gut flora, promotion of
Bifidobacteria and repression of clostridia. In the last 10 years, there has been an increasing
interest in the consumption of probiotics and functional foods in Western diets (O’sullivan,
1996). Probiotic bacteria are able to suppress potentially pathogenic microorganism in the
gastrointestinal tract and enhance the population of beneficial microorganisms (Yaeshima
et al., 1997).
The health benefits derived by the consumption of foods containing probiotic
bacteria are well documented and more than 90 probiotic products are available worldwide
(Shah, 2000). To provide health benefits, the suggested concentration for probiotic bacteria
is 106cfu/g of a product (Shah, 2000). However, studies have shown low viability of
probiotics in market preparations. A number of factors have been claimed to affect the
viability of probiotic bacteria in fermented food including acid and hydrogen peroxide
produced by bacteria, oxygen content in the product, and oxygen permeation through the
package (Shah, 2000). Viability of probiotic bacteria in fermented products declines over
time because of the acidity of the product, storage temperature, storage time, and depletion
of nutrients (Dave & Shah, 1997). Loss of viability of probiotic bacteria occurs in
fermented products, and these products have limited shelf life (Dave & Shah, 1996).
However, in order to achieve maximum viability in a product, in the gut and maximum
health benefits, there is a need to have a better understanding of this organism as an
emerging probiotic.
During use and under storage the probiotic should remain viable and stable, and be
able to survive in the intestinal ecosystem, and be able to survive in the ecosystem, and
the host animal should gain beneficially from harbouring the probiotic. It is therefore
proposed that the exogenous bacteria reach the intestine in an intact and viable form, and
establish therein and exert their advantageous properties. In order to do so, microbes must
4
overcome a number of physical and chemical barriers in the gastrointestinal tract. These
include gastric acidity and bile acid secretion. Moreover, on reaching the colon the
probiotics may be in some sort of stressed state that would probably compromise chances
of survival.
1.2 Synbiotics
When prebiotics are combined with probiotics, their relationship is classified as
synbiotic. A synbiotic is a combination of probiotics and prebiotics that “ beneficially
affects the host by improving the survival and the implantation of live microbial dietary
supplements in the gastro intestinal tract by selectively stimulating the growth and/or by
activating the metabolism of one or a limited number of health promoting bacteria”
(DiRienzo, 2000).This combination can improve the survival rate of the probiotics and
provide additional health benefits to the host [Collins and Gibson, 1999]. Thus together
probiotics and prebiotics have health promoting effects as well as develop of products
assortment.
1.3 Viability of Probiotic organisms
Microorganisms introduced orally have to, at least, transiently survive in the
stomach and small intestine. Although this appears to be a rather minimal requirement,
many bacteria including the yoghurt-producing bacteria L. delbrueckii subsp. bulgaricus
and S. thermophilus often do not survive to reach the lower small intestine. The reason for
this appears to be low pH of the stomach. In fasting individuals, the pH of the stomach is
between 1.0 and 2.0 and most microorganisms, including lactobacilli, can only survive
from 30 seconds to several minutes under these conditions. Therefore, in order for a
probiotic to be effective, even the selection of strains that can survive in acid at pH 3.0 for
sometime would have to be introduced in a buffered system such as milk, yoghurt or other
food. Lankaputhra and Shah (1995) showed that, among several strains of L. acidophilus
5
and Bifidobacterium sp. studied, only a few strains survived under the acidic conditions
and bile concentrations normally encountered in fermented products and in the
gastrointestinal tract, respectively. Therefore, it cannot be generalised that all probiotic
strains are acid and bile tolerant. Clark et al. (1993) and Lankaputhra and Shah (1995)
showed that Bifidobacterium longum survives better in acidic conditions and is able to
tolerate a bile concentration as high as 4%.
1.4 Microencapsulation of Probiotics
Micro encapsulation was developed as the technology to improve the stability and
viability of free cells due to their sensitivity to the acidic media and oxygen (Fung et al.,
2011; Nag et al., 2011; Pedroso et al., 2012). Moreover, the higher cell viable should be
remained because they should pass through the stomach and intestine to provide beneficial
effects (Chandramouli et al., 2004).Micro encapsulation has always been used for
providing the controlled release property for cell in the coating materials (Dembczynski et
al., 2002; Lee et al., 2004; Picot et al., 2004; Ma et al., 2014; Xing et al., 2014). As
reported by Chandramouli et al. (2004), the condition for protecting Lactic acid bacteria
was optimized. Picot et al. (2004) also found that the viable cell counts of Bifidobacterium
breve R070 and Bifidobacterium longum R023 in micro encapsulation using the whey
protein as the coating materials was increased during storage at the low temperature. As
reported by Mandal et al. (2006), the survival of coated Lactobacillus casei was better than
that for free cells at heat treatment. Moreover, according to Ding et al. (2009), during both
processing and storage, micro encapsulation could improve the survival of
microorganisms. According to the investigation of Xing et al. (2014) and Ma et al. (2014),
Lactobacillus acidophilus was also embedded with porous starch as the coating material.
Therefore, microencapsulated cell is drawing more and more interesting of many
researchers in order to improve its stability during application (Semyonov et al., 2010).
6
Micro-encapsulation and added prebiotic substances in probiotic products have been used
satisfactorily to increase the survival of probiotic organisms in high acid fermented
products such as yoghurts. Khalida et al (2000) reported a modified method involving
calcium-alginate-starch micro-encapsulation. In this study the encapsulated L. acidophilus
and Bifidobacterium spp were incorporated and set yoghurt was made and stored for 8
weeks at 40C. This study demonstrated that survival of encapsulated cultures of L.
acidophilus and Bifidobacterium showed a better survival over an 8 weeks storage period
compared to the survival of free cells.
Some authors have shown that the freezing process affects dramatically the number
of live probiotic cells (Kailasapathy and Sultana, 2003). Encapsulation has been
investigated for improving the viability of microorganisms in both dairy products and the
GI tract (Krasaekoopt et al., 2003 and Picot and Lacroix, 2004). The co-encapsulation of
probiotic with prebiotic improved the survival rate of probiotics (Chen et al., 2005).
Beneficial health properties of probiotics, prebiotics and other functional
compounds strengthened the production, the offer and requirement of functional food
products and/or pharmaceuticals worldwide. The efficacy of the administered functional
products containing probiotic bacteria largely depends on the viability of the cells and their
release in the lower intestine in sufficient number. Different techniques of
microencapsulation have been used as a potential tool to enhance the viability of probiotics
and to control release of these cells across the intestinal tract (Burgain 2011, Cook, 2012).
It is important the encapsulation method applied does not reduce viability of the cells and
does not inhibit their activity which includes resistance of the cells to gastrointestinal
environment and their ability to adhere to intestinal mucosa.
Examples of biomaterials often applied to encapsulate bacterial cells include
alginate, gelatin, chitosan, carrageenan, whey proteins, cellulose acetate phthalate, acacia
7
gum, gellan and xanthan gum and starches (Burgainand Gaiani 2011 and Cook MT,
Tzortzis 2012). Alginate beads are sensitive to the acidic environment, while cellulose
acetate phthalate and mixture of gellan-xanthan are not soluble at acidic pH and enable
high resistance towards acid conditions. Amphoteric nature of gelatin and whey protein
allows favorable interaction with anionic polysaccharides when the pH is adjusted below
the isoelectric point of the protein component thus the net charge of the protein becomes
positive (Harnsilawat T, Pongsawatmanit 2006). The behaviour of the proteins below their
isoelectric point encourages cooperation between proteins and polysaccharides in terms of
higher survival rate of probiotics during processing and after consumption. Due to certain
advantages and disadvantages of an applied method of encapsulation and coating agents,
it is important to compare different biomaterials and encapsulation methods using the same
probiotic strain.
Sodium alginate is often applied for encapsulation of probiotic cells due to its low
cost, biocompatibility and suitability to form gels easily by selective binding of divalent
ions, while properly resolve in the intestine and release entrapped cells. Alginate
microparticles improved survival of L. casei NCDC-298 in simulated GI conditions and
exposure to heat (Mandal and Puniya, 2006) and had no negative effect on adhesion of
probiotic cells to HT-29 cell line of the human epithelium. However, alginate particles are
sensitive to acid medium and they can be easily disintegrated in the presence of
monovalent ions or salts as phosphates, lactates and citrates which bond calcium ions.
Additional disadvantage of alginate particles is their porous surface (Gouin, 2004). On the
other hand, the polyelectrolyte nature of alginate enables improving its properties as
encapsulating agent by creating of electrostatic interaction with other polymers or by using
additives to cause structural modifications of alginate (Krasaekoopt and Bhandari, 2003).
Micro-encapsulation and added prebiotic substances in probiotic products have been used
8
satisfactorily to increase the survival of probiotic organisms in high acid fermented
products such as yoghurts.
1.5 Scope of present investigation
Probiotic functionality depends on the ability of a strain to confer health advantages
on the host upon oral consumption of viable cells. In recent times, there has been a growing
appreciation for the important role of commensal microbiota in human health. This has led
to attempts to manipulate or augment the microbiota through the use of probiotics (live
microorganisms that when administered in adequate amounts confer a health benefit on
the host) or prebiotics (non-digestible substances that provide a beneficial physiological
effect on the host by selectively stimulating the favourable growth or activity of a limited
number of indigenous bacteria).
In the recent past, there has been an explosion of probiotic health-based products.
Many reports indicated that there is poor survival of probiotic bacteria in these products.
Further, the survival of these bacteria in the human gastro-intestinal system is
questionable. Providing probiotic living cells with a physical barrier against adverse
environmental conditions is therefore an approach currently receiving considerable
interest. The technology of microencapsulation of probiotic bacterial cells evolved from
the immobilised cell culture technology used in the biotechnological industry.
Microencapsulation is a process by which individual particles or droplets of solid or liquid
material (the core) are surrounded or coated with a continuous film of polymeric material
(the shell) to produce capsules in the micrometer to millimeter range, known as
microcapsules. The capsule has a core surrounded by a thin membrane and the membrane
serves as a barrier to LAB release. After encapsulation technique was introduced,
microencapsulation techniques were successfully used to improve the survival of
microorganisms in dairy products (Adhikari et al., 2002). The most commonly reported
9
microencapsulation procedure is based on the calcium alginate gel capsule formation.
Kappa-carrageenan, gellan gum, gelatin and starch are also used as excipients for the
micro-encapsulation of probiotic bacteria.
1.6 Objectives of the present investigation
The objectives of the present work were the following:
Production of Probiotic and synbiotic yogurt.
Analysis of physico-Chemical and microbiological analysis of Probiotic and
synbiotic yogurt.
Microencapsulation of synbiotics.
To study the Survival of microencapsulated synbiotic at acidic pH of stomach and
bile salt of intestine.
To Study the efficacy of microencapsulation on synbiotic yogurt production.
10
Chapter 2
REVIEW OF LITERATURE
2.1. Yogurt
Yogurt is a product of the lactic acid fermentation of milk by addition of a starter
culture containing Streptococcus thermophilus and Lactobacillus delbrueckii ssp.
bulgaricus (McKinley, 2005). Although fermented milk products such as yogurts were
originally developed simply as a means of preserving the nutrients in milk, it was soon
discovered that, by fermenting with different microorganisms, an opportunity existed to
develop a wide range of products with different flavours, textures, consistencies and more
recently, health attributes. The market now offers a vast array of yogurts to suit all palates
and meal occasions. Yogurts come in a variety of textures (e.g. liquid, set and stirred curd),
fat contents (e.g. regular fat, low-fat and fat-free) and flavours (e.g. natural, fruit, cereal,
chocolate), can be consumed as a snack or part of a meal, as a sweet or savoury food. This
versatility, together with their acceptance as a healthy and nutritious food, has led to their
widespread popularity across all population subgroups (Mckinley, 2005). Yogurt was
introduced to the American diet during the 1940s. By the 1980s, it had become the product
for dieters, and the lunch of choice for young women. The use of yogurt as a calcium
source has made it one of the most rapidly growing dairy products, but presently it is more
than just a calcium source. Yogurt, Kefir, and similar fermented milk products are on the
way to becoming major nutraceuticals aimed at treating a variety of disease conditions
(Katz, 2001).
Yogurt gels are formed by the fermentation of milk with thermophilic starter
bacteria; milk is normally heated at high temperatures (e.g., 85°C for 30 min), which
causes the denaturation of whey proteins. Denatured whey proteins interact and cross-link
with κ-casein on the surface of casein micelles. There is increased casein-casein attraction
11
as the pH of milk decreases from ~6.6 to ~4.6 during yogurt fermentation, which results
in gelation as casein approach their iso-electric point. Physical properties of yogurt gels,
including whey separation play an important role in quality and consumer acceptance. An
understanding of gelation process during fermentation is critical in manipulating physical
properties of yogurt (Lee and Lucey, 2004).
2.2. Definition of probiotics:
The explanation of probiotics has been growing over time, which used for the first
time by Lilly and Stillwell (1965) to describe compounds produced by organisms that
stimulated the growth of another. However, Parker (1974) used this term to the substances
that applied to the animals feed as supplements in purpose of health improve by
contributing to its intestinal microbial balance. This term probiotics‘ was taken by Roy
Fuller (1989) and under a continuous work he referred to these substances as life microbes
and substances supplements and give his definition as ―a live microbial feed supplement
that beneficially affects the host animal by improving its intestinal microbial balance.
Applying probiotics to the human studies show more new definitions and the essential
requirements have been moderated to suit the future researches. Food and Agriculture
Organization/World Health Organization Working Group (FAO/WHO) (2002) recognize
probiotics as ―live microorganisms which when administered in adequate amounts confer
a health benefit on the host. But the Joint International Scientific Association for Probiotics
and Prebiotics recently adopted this definition (Reid et al., 2003) ―Probiotic bacteria are
live food supplements which benefit the health of the consumer.
12
2.3. Characteristics of Lactobacillus
Lactobacilli are characterized as Gram-positive facultative bacteria, they are non-
spore forming, non-flagellated rods or coccobacilli (Hammes and Vogel, 1995). They are
strictly fermentative, so they have the ability to ferment lactose and other monosaccharides
to lactic acid predominantly with the homo-fermenters ones and to lactic acid with carbon
dioxide and ethanol for the hetero-fomenters ones. They are well use in the diet, therefore
they claim as probiotics include Lactobacillus acidophilus, L.delbrueckii subsp.
bulgaricus, L.casei, L.fermentum, L.plantarum, L.reuteri.
2.3.1. Lactobacillus acidophilus
L. acidophilus belongs to the homofermentative Group of lactobacilli. L.
acidophilus is non-motile, non-flagellated and non-sporing. It is facultative bacteria and
Gram-positive rod around 0.6 to 0.9 μm in width and 1.5 to 6.0 μm in length with rounded
ends. Cells may appear singularly or in pairs as well as in short chains. The optimum
growth occurs within 35-40°C but it can tolerate temperatures as high as 45°C. The
optimum pH for growth is between 5.5-6. Lactobacillus acidophilus offers a range of
health benefits which include: providing immune support for infections and cancer, a
healthy replacement of good bacteria in the intestinal tract following antibiotic therapy,
reducing occurrence of diarrhoea in humans (children and adults), aiding in lowering
cholesterol, improving the symptoms of lactose intolerance. Anti-tumor effect of
L.acidophilus was reported by Goldin and Gorbach (1984). Oral dietary supplements
containing viable cells of L.acidophilus decreased ß- glucuronidases, azoreductase, and
nitroreductase, bacterial enzymes, which catalyze conversion of procarcinogens to
carcinogens. Anticarcinogenic effect of L.acidophilus may be due to direct removal of
procarcinogens and activation of body’s immune system. Animal studies have shown that
13
dietary supplementation with L.acidophilus decrease the number of colon cancer cells in
a does dependant manner (Rao et al., 1999).
2.3.2. Lactobacillus casei
Lactobacillus casei is an acid sensitive, rod-shaped, facultative hetero fermentative
lactic acid bacterium that can be isolated from a variety of environments including raw
and fermented milk and meat or plant products, as well as the oral, intestinal, and
reproductive tracts of humans and animals. It is a beneficial microorganism that helps to
promote other beneficial bacteria and prevents the overgrowth of pathogenic bacteria in
the human body. It has been reported that it can improve and intensify digestion, control
diarrhoea, reduce inflammations of the gut, reduce lactose intolerance and alleviate the
symptoms of constipation, all leading to better function of the immune system (Gill Prasad,
2008)
2.4. Regulations and safety of probiotics in manufacture:
Since the early of last century beneficial effects of probiotics have been proved and
well used in the dairy Industry, which suggested of daily intake to get the beneficial effect
on the host. That directs the research and Industry organizations to suggest special
regulations for the use of probiotics in food industry to obtain the desired therapeutic
effects. Probiotics are sensitive because they die after exposure to low pH in the human
stomach. Therefore, the high-count number of probiotics recommended in the products at
a minimum count of 106 CFU/g at the expiry date (Gomes and Malcata, 1999). The more
use of probiotics in the worldwide as dairy products the more suggested the need of
principles and regulations as standard for the minimum count of viable probiotics bacteria
in the dairy and fermented milk products to get the beneficial effects. The National Yogurt
Association (NYA) of the United States suggested that any yogurt with live culture and
use for health benefit recognize as containing significant amounts of live and active
14
cultures. The seal is a voluntary identification available to all manufacturers of refrigerated
yogurt products contain at least 108cfu per gram at the time of manufacture, and at least
107cfu per gram in frozen yogurt contains at the time of manufacture. Some countries like
Australia and New Zealand are still not introduce regulations for probiotics use. However,
the Australian and New Zealand Food Standards Code (ANZFA) doesn‘t put any
minimum count of probiotics products, but its mentioned the important of viable
organisms in the manufactured of fermented milk products and that should be at least 106
CFU/g and pH of 4.5 at the end of manufactured of yogurt.
2.5. Prebiotics
The term `prebiotic’ was first coined by Gibson and Roberfroid (1995). Prebiotic
is defined as a non digestible food ingredient that beneficially affects the host by
selectively stimulating the growth and/or activity of one or a limited number of bacteria in
the colon, that can improve the host health’. The function of prebiotics is to basically
stimulate existing metabolisms in the colon (Coussement, 1996). Thus, the prebiotic
approach advocates administration of non-viable entities and therefore overcomes survival
problems in the upper gastrointestinal tract. To be an effective prebiotic an ingredient
must: Neither be hydrolysed nor absorbed in the upper part of the gastrointestinal tract;
Have a selective fermentation such that the composition of the large intestinal microbiota
is altered towards a healthier composition.
Prebiotics, as currently conceived of, are all carbohydrates of relatively short chain
length (Cummings et al., 2001), additionally carbohydrates that have escaped digestion in
the upper gastrointestinal tract form the predominant substrates for bacterial growth in the
colon (Roberfroid et al., 1993). Short-chain fatty acids are a major product of prebiotic
breakdown, but as yet, no characteristic pattern of fermentation has been identified.
15
Through stimulation of bacterial growth and fermentation, prebiotics affect bowel habit
and are mildly laxative (Cummings et al., 2001).
Prebiotics may have many advantages over probiotics. This is firstly related to
survivability problems. These include: Maintenance of viability in the product (which, for
obvious reasons, will usually be stored under conditions adverse to bacterial growth);
Gastric acidity; Bile salts; Pancreatic enzymes and proteins; Competition for colonisation
sites and nutrients with the resident gastrointestinal flora.
Gibson (2004) stated that for a dietary substrate to be classified as a prebiotic, it
has to meet at least three requirements; (1) the substrate must not be hydrolysed or
absorbed in the stomach or small intestine, (2) it must be selective for beneficial bacteria
in the colon such as the Bifidobacteria and (3) fermentation of the substrate should induce
beneficial luminal/systemic effects within the host. A range of dietary compounds has
suggested as prebiotic, most of the selected prebiotics were on their health benefits on host.
Gibson et al. (1995) presented the popularity of Inulin, Fructo-oligosaccharides (FOS) and
Galacto-oligosaccharides (GOS) as health benefit subtracts.
2.5.1. Inulin
Inulin is a blend of fructan chains found widely distributed in nature as plant
storage carbohydrates (Wang and Gibson, 1993), and is present in more than 36,000 plant
species. The majority of inulin commercially available today is extracted from chicory
roots. Chemically, inulin is a polydisperse β-(2,1) fructan. The fructose units in the mixture
of linear fructose polymers and oligomers are each linked by β-(2,1) bonds. A glucose
molecule typically resides at the end of each fructose chain and is linked by an α-(1,2)
bond, similar to sucrose. Chain lengths of these chicory fructans range from 2-60, with an
average degree of polymerisation of 10 Inulin has natural taste, colourless and minimal
16
influence on the natural characteristics of the products. The only prebiotics for which
sufficient data have been generated to allow an evaluation of their possible classification
as functional food ingredients are the inulin-type fructans, which include native inulin,
enzymatically hydrolyzed inulin or oligofructose, and synthetic fructo oligosaccharides
(Roberfroid et al., 1998).It is fermented by the intestinal flora causing increase in the
biomass, producing of short chain fatty acids and decrease in the pH, and significant
increase of Bifidobacteria in the colon and inhibits the growth of less beneficial bacteria,
(Roberfroid, 1998). So using these ingredients in food allows improving the nutrition value
of the products, by reducing the calorie content and increasing the bifidus-promoting
capacities.
2.5.2. Lactulose
Lactulose is a synthetic disaccharide in the form Gal β1-4 fructofuranose.
Lactulose has been used as a laxative as it is not hydrolysed or absorbed in the small
intestine. However, at sub-laxative doses lactulose has received attention as a bifidogenic
factor and has been administered as such (Tamura, 1983). In vitro, lactulose increased
lactobacilli and bifidobacteria and significantly decreased bacteroides in mixed continuous
faecal culture. The feeding of lactulose to rats significantly increased bifidobacteria;
however, only a limited number of bacterial groups was enumerated (Suzuki et al., 1985).
In a human trial, bifidobacteria significantly increased while clostridia,
bacteroides, streptococci and Enterobacteriaceae decreased on the feeding of 3 g/d
lactulose to eight volunteers (five male, three female) for 14 days (Terada et al., 1992).
Small decreases in bacteroides and lactobacilli during the test period were also determined.
In addition, decreases in the detrimental metabolites ammonia, indole, phenol, p-cresol
and skatole, and enzymes β-glucuronidase, nitroreductase and azoreductase supported
beneficial claims of lactulose.
17
2.6 Factors affecting the growth and survival of Lactobacillus
The consumption of probiotic bacteria within food products is the most popular
way to re-establish the gastrointestinal microflora balance. The literature had stated that
probiotic products have to present no less of 106cfu in ml of probiotic bacteria at the time
of consumption to get the beneficial health on the host (Adhikari et al., 2003).
Dairy products is one of the most common carrier have been used as probiotic food
products. Therefore, it is of interest to study some factors that affect the growth and
survival of probiotic bacteria while in transit in dairy products to human use. Many factors
have been reported to affect the growth and survival of probiotic bacteria in dairy products,
including acid and hydrogen peroxide produced by yogurt bacteria, oxygen content in the
product and oxygen permeation through the package and the storage temperature (Dave
and Shah 1997) suggested of using ascorbic acid in dairy products as scavenger to reduce
the oxygen content and redox potential of dairy products to enhance the viability of
probiotic bacteria.
The interaction among probiotic species and yogurt starter cultures is also
considered important in determining their growth and survival status in dairy products.
Various inhibitory interactions were found among these bacteria (Dave and Shah, 1997).
Growth and survival of probiotic bacteria has also found to be affected by the chemical
and microbiological composition of milk, milk solids content, and availability of nutrients
(Shah, 2000).
Viability and survival of probiotic bacteria are the most important parameters in
order to provide therapeutic functions. A number of factors have been claimed to affect
the viability of probiotic bacteria in dairy foods such as yoghurt and fermented milks,
including low pH and refrigerated storage (Shah, 2000). Micro-organisms ingested with
food begin their journey to the lower intestinal tract via the mouth and are exposed during
18
their transit through the gastrointestinal tract to successive stress factors that influence
their survival (Marteau et al., 1993). The time from entrance to release from the stomach
is about 90 min, but further digestive processes have longer residence times (Berrada et
al., 1991).
Cellular stress begins in the stomach, which has pH as low as 1.5 (Lankaputhra &
Shah 1995). Bile secreted in the small intestine reduces the survival of bacteria by
destroying their cell membranes, whose major components are lipids and fatty acids and
these modifications may affect not only the cell permeability and viability, but also the
interactions between the membranes and the environment (Gilliland, 1987).
One of the important characteristics of the microorganisms is their ability to
survive through the acidic conditions in the human stomach and bile concentrations in the
intestine and colonise in the gut. For this to occur, viable cells of Lactobacillus must be
able to survive the harsh condition of acidity and bile concentration commonly
encountered in the gastrointestinal tract of humans.
2.7. Effect of prebiotics on probiotic growth and survival
Synbiosis is defined as ―a mixture of probiotics and prebiotics that beneficially
affects the host by improving the survival and implantation of live microbial dietary
supplements in the gastrointestinal tract, by selectively stimulating the growth and/or by
activating the metabolism of one or a limited number of health-promoting bacteria, and
thus improving host welfare (Gibson and Roberfroid, 1995). In recent years, there has been
more focus on a combination of pre-and probiotics in a single product.
Fructooligosaccharide and Inulin are the premium prebiotics used for the purpose of
stimulating the growth and/or activity of beneficial bacteria in the large intestine.
19
Inulin and Fructooligosaccharides have their stimulating effect because of their
ability to be fermented by Bifidobacteria and Lactic acid bacteria in vivo (Gibson et al.,
1995) and in vitro. However, recent studies have determined that the ability of
Bifidobacteria to metabolize fructo-oligosaccharides and inulin is a species-dependent
feature and only to a small extent a strain-dependent one related to their enzyme content.
Prebiotic ingredients have also been used as encapsulating agents. Their
advantages over other covering materials rely on the fact that, besides being nondigestible
carbohydrates, they also have beneficial effects for the host, by selectively stimulating the
growth and/or activity of probiotic bacteria (prebiosis) within the colon (Fritzen-Freire and
others 2012). Unlikely to this, greatest stability of encapsulated GG was detected during
cold storage of prebiotic edible films supplemented with inulin (Soukoulis et al., 2014). In
the study of Fritzen-Freire et al. (2012), oligofructose-enriched inulin was found to better
protect Bifidobacterium BB-12 during storage of the microcapsules produced by spray-
drying, although oligofructose showed good protection as well. The divergence of the
reported results is difficult to be explained since clear evidences on the specific protective
action of the prebiotics such as FOS or inulin for each probiotic has not been provided yet
(FritzenFreire et al., 2012).
2.8 Microencapsulation Technique
To improve the survival of LAB, different approaches that increase the resistance
of these sensitive microorganisms against adverse conditions have been proposed,
including appropriate selection of acid- and bile-resistant strains, use of oxygen-
impermeable containers, two-step fermentation, stress adaptation, incorporation of
micronutrients, however, these methods had only a limited success. Therefore,
encapsulation of bacterial cells in alginate gels is currently gaining attention to increase
viability of probiotic bacteria in acidic products such as yoghurt and it is the commonly
20
used technique because this method is very mild and is done at room temperature in
aqueous medium by using physiologically acceptable chemicals. Encapsulation is a
process in which the cells are retained within an encapsulating membrane to reduce cell
injury or cell loss and it has been widely utilized to protect microorganisms including
probiotics during transit through the human gastro-intestinal tract (Petreska et al 2014).
The microbial cells are entrapped within their own secretions (exopolysaccharides (EPS))
that act as a protective structure or a capsule, reducing the permeability of material through
the capsule and therefore less exposed to adverse environmental factors such as gastric
acid and bile salts.
Carbohydrate polymers such as alginate have been used in various food
applications (Mladenovska and Raicki 2007). Alginate, a natural polysaccharide found in
brown algae, is a linear 1, 4 linked copolymer of -D-mannuronic acid (M) and -L-guluronic
acid (G) and has the benefits of being non-toxic to the cells being immobilized and it is an
accepted food additive. The reversibility of encapsulation, i.e. solubilizing alginate gel by
sequestering calcium ions, peptides and amino acids and the possible release of entrapped
cells in the human intestine are other advantages. However, alginate beads are not acid
resistant and it has been reported that the beads undergo shrinkage and decreased
mechanical strength during lactic fermentation (Mladenovska K, Cruaud O, 2007).
Gelatin is a protein derived from denatured collagen that contains high levels of
hydroxyproline, proline and glycine and is useful as a thermally reversible gelling agent
for encapsulation. Gelatin was selected here because of its excellent membrane-forming
ability, biocompatibility and non-toxicity. The applicability of gelatin as a hydrogel matrix
is limited because of its low network rigidity. However, its physical properties can be
improved through the addition of cross-linking agents. Because of its amphoteric nature,
21
it also is an excellent candidate for cooperation with anionic polysaccharides such as
alginate and so on (Smilkov et al 2013).
A symbiotic pastry product was previously prepared by incorporating free or
encapsulated Lactobacillus casei NCDC 298 in sodium alginate in milk chocolate together
with inulin [Mandal et al 2012]. Although cell encapsulation resulted in significant
increase of cell survival at low pH, high bile salt concentration, and during heat treatment,
the viable counts of both free and encapsulated L. casei NCDC 298 were unchanged during
the storage of milk chocolate at refrigerated conditions up to 60 days and were higher than
the recommended level by International Dairy Federation guidelines (107 cfu/g) at the end
of the product shelf-life [Mandal et al 2012]. Feeding of the symbiotic chocolate increased
the fecal lactobacilli and decreased fecal coliforms and β-glucuronidase activity in mice,
indicating that it might constitute an excellent food for delivery of probiotic lactobacilli
[Mandal et al 2012].
On the contrary, encapsulation of Lactobacillus acidophilus ATCC 4356 on
calcium alginates had no effect on cell survival compared to free cells during refrigerated
storage of yoghurts for 4 weeks [Ortakci and S. Sert 2012]. However, significantly greater
survival of encapsulated over free probiotic bacteria was observed in the in vitro assays
using artificial human gastric digestion systems [Ortakci and S. Sert 2012].
Calcium alginate microspheres can be produced by both extrusion and emulsion
techniques Extrusion is the oldest and the most common approach to make capsules with
hydrocolloids and might be achieved by simply dropping an aqueous solution of probiotics
into a gelling bath. The size and shape of the beads usually range 2–5 mm and depend on
the diameter of the needle and the distance of free fall [Krasaekoopt et al, 2003]. It offers
a small range size (smaller than emulsion), but it does not provide particles under 300 μm
[Burgain et al 2011]. Extrusion is more popular than emulsion technology due to its
22
simplicity, easy handling, low cost at least to small scale, and gentle formulation
conditions, which ensure maintenance of high cell viability (80–95%) [Krasaekoopt et al,
2003].
23
Chapter 3
MATERIALS AND METHODS
3.1 Materials
Lyophilized cultures of Probiotic bacteria, Lactobacillus acidophilus (ATCC 4356,
NCDC 014), Lactobacillus casei (NCDC 018)were obtained from National Collection of
Dairy Cultures (NCDC), Dairy Microbiology Division, NDRI, Karnal , Haryana and
commercial yogurt culture containing Streptococcus thermophilus and L. delbrueckii ssp.
bulgaricus were obtained from Kerala Agricultural university, Mannuthy.
MRS and M17 broth and agar, Skim milk powder, Prebiotics (Lactulose and
inulin), Phosphate buffer saline (PBS) - pH 7.2, Bile, Pepsin, Sodium alginate, Gelatin,
Calcium Chloride (Himedia, Mumbai).
High speed refrigerated centrifuge (KHSRC-1, Kemi), pH meter (scientific tech-
ST-2001), BOD incubator (KBOD 6S, KEMI 3),Remi Mini Rotary shaker (RS-12R),
0.25-mm needle.
Figure 3.1. Gram stained preparation of (a) L.acidophilus and (b) L. casei.
(a) (b)
24
3.2 Methodology
3.2.1 Preparation of cell suspension
Pure culture of Lactobacillus acidophilus (ATCC 4356, NCDC 014) Lactobacillus
casei (NCDC 018) and L. delbrueckii ssp. bulgaricus propagated in MRS ( de Man-
Rogasa-Sharpe) agar media and broth and Streptococcus thermophilus were in M17broth
and agar for 24 hours under aerobic conditions at 37°C.Biomasses were then harvested
by centrifuging at 5000 rpm for 10 min at 4 °C. The cell pellets were then resuspended in
10 mL phosphate buffer solution (PBS) to obtain a final cell counts of 6×108 CFU/gm.The
cultures were then washed twice by sterile PBS and resuspended in pasteurised (630C for
30 min) 10 % reconstituted skim milk (RSM).
3.2.2 Production of Probiotic yogurt
Homogenized, standardized and pasteurized milk (3.62% protein, 3.61% lactose,
1.6% fat and 9.70% total solid) was used for preparation of probiotic yogurt. All yogurt
samples were produced in hygienic conditions. Milk was heated up to 85°C for 30 min
followed by cooling down to 40°C. The yogurt starter culture was then added at a
concentration of 1:1 in all samples. Experimental preparations of yogurt including control
plain yogurt in Homogenised pasteurized milk (T1), yogurt containing 1% Lactobacillus
acidophilus (T2), yogurt containing 5% Lactobacillus acidophilus (T3), yogurt containing
10 % Lactobacillus acidophilus (T4) probiotic yogurt containing 1%, 5% and 10%
Lactobacillus casei (T5,T6,T7 respectively). The mixtures were subsequently poured into
250-ml plastic cups and incubated at 43°C and fermentation was stopped at pH 4.5 – 4.7.
Then the samples were kept at 4°C. Physicochemical characteristics (pH, titratable acidity,
syneresis) and viability of probiotic bacteria in this sample were evaluated during 21-days
of refrigerated storage.
25
3.2. a. Determination of pH
pH of the milk and yogurt samples was determined with a pH meter(scientific tech-
ST-2001) at room temperature. pH was determined in a single cup of yogurt per replication
1, 2, 3,and 4 h after inoculation, and in three cups (Lactobacillus acidophilus and
Lactobacillus casei) of yogurt per replication at every 7 days of storage.
3.2. b. Determination of titratable acidity
Titratable acidity was determined in yogurt samples at room temperature according
to the methods described in AOAC (2002). Yogurt samples (10 g) were diluted with 10
ml distilled water and titrated with 0.1 N NaOH in the presence of 0.1 % phenolphthalein.
Titratable acidity was expressed as the percent of lactic acid based on the sample weight.
Titratable acidity was determined in a single cup of yogurt after 4 hours of inoculation,
and in three cups of yogurt at every 7 days of storage at 40 C.
3.2. c. Enumeration of L. acidophilus and L.casei in yogurt
SPC, a conventional method to determine cell count, was used to quantify viable
L.acidophilus and L.casei cells. One gram of yogurt sample was diluted with 99 mL of
sterile phosphate buffer saline (PBS), pH 7.2 (Himedia, Mumbai) Subsequent 10-fold
serial dilutions were made with PBS, and 0.1 mL of the diluted Samples was spread on
MRS-bile agar. After aerobic incubation at 37 °C for 48–72h, CFU/g was calculated.
[Tharmaraj and Shah, 2003]
3.2. d. Determination of Syneresis
To measure syneresis, at first, 25g of yoghurt weighed in centrifuge tubes, then the
tubes were centrifuged in 350 G at 10°C for 30 min. The separated liquid from the sample
that collected in the top of tube was removed and the tubes were re-weighed. Syneresis
rate was expressed as lost water per 100g of yoghurt (Gonzalez – Martinez et al., 2002).
26
3.3. Production of Synbiotic yogurt
Set yogurt was prepared using milk with 3.5 % fat that was standardized to 8.5%
solids not fat. Milk was preheated to 40°C.Inulin and Lactulose at a concentration of 1%
were added separately. Milk samples were heated at 85°C for 30 min, then cooled down
to 40°C for inoculation. The samples were inoculated with yogurt culture (1%) and
probiotic culture -Lactobacillus acidophilus and Lactobacillus casei (1%) separately. The
inoculated samples were mixed thoroughly and dispensed in 500 ml polystyrene cups with
lids then incubated at 43 °C until the pH dropped to 4.7-4.5. Control samples did not
contain any prebiotics. Duplicate bottles of each treatment were prepared. The
fermentation was stopped by transferring the cups immediately to refrigerator maintained
at 4°C.
Physicochemical characteristics (pH, titratable acidity and syneresis) and viability
of probiotic bacteria in both sample were evaluated during 28-days of refrigerated storage.
3.3. a. Physicochemical and Microbial analysis of Synbiotic yogurt
pH value of samples was measured using Digital pH-meter (Scientific Tech) at
250C. Titratable acidity was determined by AOAC method [2002]. Syneresis was
measured according to Gonzalez–Martinez et al.2002 method.
MRS – bile agar was used for the selective enumeration of probiotic bacteria in the
presence of yogurt bacteria. The plates were incubated aerobically at 37°C for at least 72
hours [Tharmaraj and Shah, 2003]. Relative survival for each strain was determined by
dividing CFU/gm on 28 day by the initial cell count and then multiplied by 100.
3.4 Microencapsulation of Probiotic Cultures
All glassware and solutions used in the protocols were sterilized at 121 °C for 15
minutes. The preparation of encapsulated microcapsules was a modified version of
27
methods basically reported by Donthidi et al. in 2010 and Sultana et al. in 2000. Briefly,
2 gm sodium alginate(Hi media, Mumbai) was added to 100 ml distilled water and boiled
until it formed a gel, then to another 2% sodium alginate, 2% gelatin (Hi media ,Mumbai)
was separately added and required concentrations of inulin (1%) and Lactulose (1%) were
added separately and stirred until they were dissolved or dispersed. Then probiotic
cultures of each bacterial species (L.acidophilus and L.casei) were transferred to the carrier
solutions with stirring under sterile conditions to ensure uniform distribution of the cells.
3.4.1 Preparation of alginate microcapsule
The conditions used in the experimental work for the probiotic cells encapsulation
were: a) 2% alginate; b) 2% alginate +1% Lactulose; c) 2% alginate + 1% inulin; d) 2%
alginate + 2% gelatin; e) 2% alginate + 2% gelatin+1% Lactulose; f) 2% alginate + 2%
gelatin+1% inulin. To form capsules, a cell suspension (equivalent of 108 CFU/g) was
mixed with a 60 ml of 20 g/L alginate or alginate-gelatin with or without inulin or lactulose
and the mixture was dripped into a solution containing 0.1 M CaCl2, with a sterile syringe.
The distance between syringe and CaCl2 solution was 10 cm. The droplets formed gel
capsule instantaneously. Microscapsules were hardened for 30 min in CaCl2, and then
rinsed with sterile NaCl (8.5 g/L).
28
Figure 3.2: Microencapsulated probiotic in (a) alginate gelatin and (b) alginate beads
3.4.2 Preparation of simulated gastric and intestinal juices and inoculation of cells
The simulated juices were prepared according to Brinques et al 2011 and Michida
et al in 2006. Simulated gastric juices were prepared by dissolving pepsin (Himedia,
Mumbai) in sterile sodium chloride solution (0.5%, w/v) to a final concentration of 3.0 g/L
and adjusting the pH to 1.5 with hydrochloric acid. Simulated intestinal juices were
prepared in sterile sodium chloride solution (0.5%, w/v), with 4.5% bile salts (Oxoid,
Basingstoke, UK) and adjusting the pH to 8.0 with sterile NaOH (0.1 M). Both solutions
were filtered for sterilization through a 0.22 μm membrane. The probiotic bacteria
L.acidophilus and L. casei were inoculated to the simulated gastro-intestinal juice
individually in six different forms, non-encapsulated, encapsulated with calcium alginate
and calcium alginate-gelatin coated with inulin or Lactulose as prebiotic. Further one gram
of freshly encapsulated bacteria samples or 1 mL of cell suspensions (free cells) were
gently mixed with 10 mL of sterile simulated gastric juice (SGJ) for 2 hours at 370 C and
followed by inoculation in sterile simulated intestinal juice (SIF) and incubated at 37 °C
for 4 hours.
29
3.4.3 In vitro release studies (GIT)
To examine the release behaviour of L.acidophilus and L.casei from microcapsules
in GIT in vitro, 1 ml of free bacteria and 1 gram encapsulated samples (probiotic bacteria
with or without prebiotic and alginate and or gelatin as encapsulating material) were added
to 10 ml SGF (pH 1.5) and incubated at physiological temperature (37 0 C) for 2 hours and
subsequently transferred into SIF (pH 8) for another 4 hours. At specific time intervals
(1 hour), 2.0 ml aliquots were removed and absorbance was measured at 600 nm in
triplicate.
3.4.4 Release of entrapped bacteria
The capsules containing probiotic bacteria were released by citrate buffer
(pH= 6.0, 1 %) reported by Mokarram et al in 2009. One gram of capsules was transferred
to 9 ml buffer. The solution was stirred on a shaker for 15 min vigorously until the bacteria
from the capsules were released completely. The counts (CFU/g) were determined by
plating on MRS agar plates and incubating for 48 hours at 37 °C. The free bacteria were
treated similarly. All samples were counted in triplicates. Encapsulation yield (EY) i.e. the
number of bacterial cells that survived the process and encapsulated inside the
microcapsules was calculated as follows:
EY = (N/N0) × 100
Where N0 is the number of viable bacteria in CFU/gm of culture and N is the number of
viable bacteria in CFU/g of microcapsules.
3.5. Co-encapsulated Synbiotic Yogurt Production
A set-type yogurt was prepared for this experiment. Homogenized whole milk (5
L) containing 3.5% fat, 8.5% solid-not-fat was heated to 45 °C. This was then heated to
85 °C for 20 min and allowed to cool. Once the standardized milk had cooled to 45 °C, a
30
commercial yogurt starter culture was inoculated (1% w/v) into it. The probiotic cultures
were added as free and co-encapsulated Probiotic cultures (Lactobacillus acidophilus and
Lactobacillus casei). The acidification profile was recorded hourly until a pH of 4.7-4.5
was reached. Fermentation was stopped by quickly cooling the yogurt. The filled yogurt
cups (200 ml) were stored at 4°C.
Physicochemical characteristics (pH, titratable acidity, syneresis) and viability of
probiotic bacteria in all sample were evaluated during 28-days of refrigerated storage.
Data analysis
The data were statistically analysed using the SPSS Software (version 17.0). In all
experiments, paired t-test was applied for sample comparison. This was done to test for
any significant differences (P<0.05) in the mean value of all the groups.
31
Chapter 4
RESULTS AND DISCUSSION
4.1. Preparation of cell suspension
Lyophilized cultures of Probiotic bacteria (Lactobacillus acidophilus,
Lactobacillus casei) and commercial yogurt culture containing L.delbrueckii ssp.
bulgaricus and Streptococcus thermophilus were propagated in MRS (de Man-Rogasa-
Sharpe) media .The cultures were harvested by centrifuging at 5000 rpm for 10 minutes at
4 °C then washed twice by sterile saline solution (0.9%) and resuspended in pasteurised
(630C for 30 min) 10 % reconstituted skim milk (RSM).
4.2 Production of Probiotic yogurt
Probiotic yogurt was prepared using Homogenized, standardized and Pasteurised
milk. Physicochemical characteristics (pH, titratable acidity, syneresis) and viability of
probiotic bacteria in this sample were evaluated during 21-days of refrigerated storage was
shown in Table 4.1 to 4.4
4.2. a. pH of Probiotic yogurt during storage at 40C
pH of yogurt prepared by Homogenised Pasteurised milk (T1-T7)vary between
4.30 to 4.55 during 4 hours of fermentation. Although no statistically significant difference
was observed in the pH of the treatment groups, the pH was found to be lower in T7(yogurt
containing 10% L.casei) after 4 hours of fermentation. The decline in pH of the batches of
yoghurt obtained during 21 days of refrigerated storage is shown in Table 4.1. The decline
in pH was similar for all the batches of yoghurt. Greater change in pH of about 0.62 was
observed for T4 (10 % L.acidophilus) and control sample containing yogurt culture
showed the least change (0.43).
32
Table 4.1: pH of various yogurt samples Homogenized, pasteurized milk (T1-T7) during
incubation period and storage up to 21 days
*Yogurt
Samples pH of yogurt for various incubation periods
4 hour 7(Day) 14(Day) 21(Day)
T1 4.55 4.35 4.15 4.12
T2 4.53 4.45 4.11 4.05
T3 4.41 4.21 3.92 3.89
T4 4.34 4.09 3.85 3.72
T5 4.53 4.33 4.15 4.06
T6 4.51 4.11 4.03 3.99
T7 4.30 4.20 3.90 3.84
*Yogurt Samples- T1- control plain yogurt in Homogenised pasteurized milk
T2-yogurt containing 1% Lactobacillus acidophilus, T3-yogurt containing 5%
L.acidophilus, T4- yogurt containing 10 % L.acidophilus,
T5,T6,T7 -Probiotic yogurt containing 1%, 5% and 10% Lactobacillus casei respectively.
4.2. b. Titratable acidity (% Lactic acid) Probiotic yogurt during storage at 40C
Titratable acidity of Probiotic yogurt prepared using Homogenised Pasteurised
milk was shown Table 4.2. There was an increase in acidity by the addition of both
probiotic cultures, but it was within limit (0.9) up to 14 days except T4 (10%
L.acidophilus). At 21 day in all samples including control, acidity goes beyond limit. So,
as the concentration of inoculum increases acidity also increases.
Table 4.2: Titratable acidity of Probiotic yogurt samples Homogenized, pasteurized milk
(T1-T7) during incubation period and storage up to 21 days
*Yogurt
samples
Titratable acidity
4 hour 7(Day) 14(Day) 21(Day)
T1 0.53 0.56 0.68 1.012
T2 0.75 0.79 0.95 1.01
T3 0.76 0.79 0.86 1.12
T4 0.77 0.79 1.23 1.35
T5 0.41 0.45 0.69 1.01
T6 0.50 0.56 0.9 1.03
T7 0.72 0.79 0.97 1.23
33
4.2. c. Bacterial counts of Probiotic yogurt during refrigerated storage at 40C
Probiotic bacterial count decreased significantly during refrigerated storage at 4 0
C (Table 4.3). After 4 hours of incubation maximum cell count was shown by yogurt
inoculated with 1% L.casei, and it also showed greater survival after 21 days of storage.
In all other samples, inoculated with probiotic bacteria, number of cells fall below 10 7
CFU/gm after refrigerated storage. For dietary cultures to be beneficial in food systems,
they are expected to be viable in the food until the time of consumption and present at
levels of at least 107 viable cells per gram or milliliter of a product (Shah and Lankaputhra,
1997; Dave and Shah, 1997).
Table 4.3: Bacterial count of Probiotic yogurt samples (T2-T7) during incubation period
and storage up to 21 days
*Yogurt
Samples Cell count(Log CFU/gm)
4 hour 7(Day) 14(Day) 21(Day)
T1 - - - -
T2 7.47 7.39 7.39 6.69
T3 7.59 7.27 6.98 6.54
T4 7.76 7.33 7.16 6.92
T5 7.82 7.76 7.60 7.40
T6 7.40 7.30 7.29 6.94
T7 7.60 7.40 7.38 6.60
The main factors for loss of viability of probiotic organisms have been attributed
to the decrease in the pH of the medium and accumulation of organic acids as a result of
growth and fermentation (Shah, 2000).
4.2. d. Syneresis of Probiotic yogurt during storage at 40C
In the first week of storage, syneresis of control sample had lower level as
compared to the other samples while syneresis percentage then increased significantly.
34
Least syneresis was shown by milk inoculated with 10 % L.acidophilus and L.casei after
4 hours of fermentation, but after 21 days they showed maximum syneresis (Table 4.4).
Table 4.4: Syneresis of Probiotic yogurt samples (T1-T7) during incubation period and
storage up to 21 days.
*Yogurt
Samples Syneresis (%)
4 hour 7(Day) 14(Day) 21(Day)
T1 7.5 7.5 7.5 10
T2 8.75 9.25 10 10
T3 7.75 8.25 9 10
T4 5 7.5 11.3 12.5
T5 7.5 7.5 9.75 10.75
T6 8 9.75 10.25 12.5
T7 5 7.5 8 10.25
As the inoculum concentration of probiotic bacteria increased there was a decrease
in pH and probiotic bacterial count below therapeutic limit in probiotic yogurt during 28
days of storage at 40C. Therefore, alternative methods like production of synbiotic yogurt
was adopted.
4.3. Synbiotic yogurt Production
Synbiotic yogurt was prepared by the incorporation of Inulin and Lactulose (1%)
separately into the probiotic yogurt containing Lactobacillus acidophilus and
Lactobacillus casei. When the pH of the sample reached in between 4.5-4.7, samples were
stored at 4°C for 28 days and during this time pH, acidity, syneresis and probiotic counts
were investigated and compared to the probiotic yoghurt (with no prebiotics).
4.3. a. pH of Synbiotic yogurt during storage at 40C
Changes in pH of Synbiotic yogurt containing Lactobacillus acidophilus and
Lactobacillus casei during refrigerated storage at 40C for 28 days were shown in figure
4.1. Due to lactic and acetic acid production by Lactobacillus strains, pH of all samples
35
were found to be decreased. For Lactobacillus acidophilus and L.casei, a significant
decrease in pH (p<0.05) was observed by inulin and Lactulose as prebiotic than with
control. However there was no significant difference between inulin and Lactulose
treatment during 28 days of storage for both the Probiotics.
Figure 4.1: pH of synbiotic yogurt during storage at 40C for 28 days - Lactobacillus
acidophilus and Lactobacillus casei.
4.3. b. Acidity of Synbiotic yogurt during storage at 40C
Acidity of Lactobacillus strains grown in synbiotic yogurt containing prebiotics
during 4 weeks of storage at 40C was shown in figure 4.2.As a result of the lactose
fermentation, the titratable acidity increased. This is slightly higher for the samples with
3.8
3.9
4
4.1
4.2
4.3
4.4
4.5
4.6
Day(0) Day 7 Day 14 Day 21 Day 28
pH
Days of storage
Lactobacillus acidophilus
Control
L.a +inulin
L.a +Lactulose
3.8
3.9
4
4.1
4.2
4.3
4.4
4.5
4.6
Day(0) Day 7 Day 14 Day 21 Day 28
pH
Days of storage
Lactobacillus casei
Control
L.c +inulin
L.c +Lactulose
36
prebiotic than that of control samples. For synbiotic yogurt containing L.acidophilus
increase in acidity with Inulin and lactulose was not significantly (p>0.05) differ from
control sample, but for Synbiotic yogurt containing L.casei both Inulin and Lactulose
showed significant (p<0.05) increase in acidity than control sample.
Figure 4.2: Acidity of Lactobacillus strains grown in synbiotic yogurt during 4 weeks of
storage at 40C
4.3. c. Viability of Synbiotic yogurt during refrigerated storage at 40C
During 28 days of refrigerated storage, count of L.acidophilus treated with
prebiotics (inulin and lactulose) was found to be increased in presence of prebiotics up to
7 days (figure 4.3 (a)) and thereafter decreased. For synbiotic yogurt containing
0.8
0.9
1
1.1
1.2
1.3
1.4
1.5
1.6
Day(0) Day 7 Day14 Day 21 Day 28
Aci
dit
y
Days of storage
Control
L.a +inulin
L.a +Lactulose
0.8
0.9
1
1.1
1.2
1.3
1.4
1.5
1.6
Day(0) Day 7 Day 14 Day 21 Day 28
Aci
dit
y
Days of storage
Lactobacillus casei
Control
L.c +inulin
L.c +Lactulose
37
L.acidophilus, greatest survival rate (table 4.5) was shown by sample treated with
Lactulose (71.4 %), but it was not significantly (p>0.05) differ from that with inulin (70.6
%) and the control. Dave et al. (1997) reported that pH was found to be the most crucial
for L.acidophilus culture, yogurt with pH <4.4 at the time of fermentation results in 3-4
log cycle reduction in L.acidophilus numbers within 20-25 days.
Figure 4.3: Viability of Lactobacillus strains grown in synbiotic yogurt during 4 weeks of
storage at 40C.
Yogurt containing Lactulose showed an initial increase of L.casei upto 7 days
(figure 4.3 (b) and thereafter decreased. However there was a significant difference in
bacterial count treated with prebiotic than control, with inulin showed maximum survival
5
6
7
8
9
10
11
Day(0) Day 7 Day14 Day 21 Day 28
Log
CFU
/ g
m
days of storage
L.acidophilus
Control
L.a +inulin
L.a +Lactulose
5
6
7
8
9
10
Day(0) Day 7 Day 14 Day 21 Day 28
Log
CFU
/ g
m
days of storage
L. casei
Control
L.c +inulin
L.c +Lactulose
38
rate of 81.3 %(Table 4.5).There was no significant difference in bacterial count between
in inulin than in Lactulose (80.9 %).The number of both probiotic bacteria found to be
decreased below 7.00 log 10 CFU/gm in 28 days of storage.
Table 4.5: Percentage viability of Lactobacillus strains grown in synbiotic yogurt during
4 weeks of storage at 40C.
4.3.d. Syneresis of Synbiotic yogurt during refrigerated storage at 40C
Syneresis of Lactobacillus strains grown in synbiotic yogurt containing prebiotics
during 4 weeks of storage at 40C was shown in figure 4.4. For L.acidophilus least syneresis
was shown by sample with inulin, but it was not significantly (p>0.05) differ from that of
control and sample with Lactulose, but synbiotic yogurt containing L.casei addition of
inulin had a significant (p<0.05) effect on decrease in syneresis compared to control and
lactulose.
Prebiotics
Strains
Reading
interval
Log CFU /gm of probiotic bacteria
Control Inulin Lactulose
Lactobacillus
acidophilus
Day 0 8.59 8.61 8.64
Day 28 5.81 6.08 6.17
Viability % 67.6 70.6 71.4
Lactobacillus casei
Day 0 8.6 8.58 8.6
Day 28 5.8 6.98 6.96
Viability % 67.4 81.3 80.9
39
Figure 4.4: Syneresis of Lactobacillus strains grown in synbiotic yogurt during 4 weeks
of storage at 40C.
The results showed that neither Inulin nor Lactulose had significant effect on
physicochemical properties (except pH) and probiotic bacterial survival of L.acidophilus.
Both Inulin and Lactulose had a significant effect on physicochemical changes and
probiotic bacterial survival of L.casei.
0
10
20
30
40
50
Day(0) Day 7 Day14 Day 21 Day 28
syn
eres
is %
days of storage
L.acidophilus
Control
L.a +inulin
L.a +Lactulose
0
5
10
15
20
25
30
35
40
45
Day(0) Day 7 Day 14 Day 21 Day 28
syn
eres
is %
days of storage
L. casei
Control
L.c +inulin
L.c +Lactulose
40
4.4. Microencapsulation of Synbiotics
L.acidophilus and L.casei along with prebiotic (Inulin and lactulose) have been
microencapsulated and exposed to simulated gastrointestinal fluid. Microencapsulated
synbiotics were also used for the production of yogurt.
4.4. a. In vitro release studies of L.acidophilus and L.casei from the microcapsules
Free cells and Microcapsule samples were treated with Simulated Gastric Juice
(SJG) and then with Simulated Intestinal Fluid (SIF) to check the continuous release
characteristics of L.acidophilus and L.casei in Gastro Intestinal Tract (GIT) and the results
are shown in Figure 4.5. In SJG (pH 1.5), the release amounts of cells were minor from
each sample of the microcapsule. Once the samples were transferred from SJG to SIF, the
larger amounts and faster release rate of L.acidophilus and L.casei cells were found,
indicated by an increase in absorbance. For L.acidophilus and L.casei faster release of cells
found to occur when they are encapsulated in alginate- gelatin with inulin as prebiotic
followed by Lactulose. For both probiotics, alginate- gelatin along with prebiotic were
found to gave better protection in gastric juice and better release in intestinal fluid. Further
free cells were found to be very susceptible to SIF.
41
Figure 4.5: Absorbance of free and microencapsulated (A) Lactobacillus acidophilus and
(B) Lactobacillus casei in simulated gastro intestinal juice.
4.4. b. Survival of free and microencapsulated probiotics in simulated gastric juice
The viability of free and encapsulated probiotic bacteria during incubation in the
simulated gastro-intestinal condition was shown in Figures 4.6 .Survival of probiotics was
lower in gastric juice and decreased further as the incubation period increased. Exposure
to simulated gastric juice for 120 minutes resulted in a considerable decrease in the total
number of free Lactobacillus acidophilus and L.casei (only 25.6 % & 17.9 % viability
respectively). However, the cell number of microencapsulated L.acidophilus and L.casei
decreased slightly after 120 minutes. Alginate – gelatin encapsulated L. acidophilus was
observed to exhibit the highest viability (94.11%) when inulin was incorporated as
prebiotic while greatest viability of 84.94 % was observed for alginate encapsulated
L.casei without any prebiotic. In the case of both L. acidophilus and L.casei, the survival
of cells in both alginate and alginate-gelatin were found to be higher when compared with
free cells. Chávarri in 2010 reported that encapsulation in chitosan-coated alginate
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
30
M
1
H
2
H
3
H
4
H
5H6H
O.D
at
60
0 n
m
Time (hours)
(A)
Free cells
L.acidophilus
L.a+lact.+ Alg.
L.a +inl+Alg
L.a+alg
L.a +Alg.gel
L.a +Alg.gel+ lact.
L.a +Alg.gel+inl.
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
30M
1H
2H
3H
4H
5H 6H
O.D
at
60
0 n
mTime (hours)
(B)Free cellsL.acidophilus
L.c+lact.+ Alg.
L.c +inl+Alg
L.c+alg
L.c +Alg.gel
L.c +Alg.gel+ lact.
L.c +Alg.gel+inl.
42
microcapsule significantly improved the survival of Lactobacillus gasseri and
Bifidobacterium bifidum in simulated gastric juice along with pepsin. Many scientists have
also reported that the survival rate of Bifidobacteria in alginate microcapsules was higher
than that of free cells (Hansen et al 2002; Yu et al 2001; Woo et al 1999). Many studies
have shown coating the alginate matrix could increase the survival of bacteria due to
curbing the diffusion of calcium ions outside of capsules (Chávarri 2010; Mokarram 2009;
Krasaekoopt et al 2004). Mokarram et al in 2009 showed that L.acidophilus and
L.rhamnosus exposed to simulated gastric juice without pepsin had higher viability when
encapsulated in calcium alginate with double coating sodium alginate. They indicated that
the reduction of pore size and distribution of gastric juice in double layer membrane lead
to limitation of interaction between cells with the gastric juice. According to our study,
microcapsules both alginate and gelatin coated along with prebiotic (lactulose or inulin)
provided the best protection in simulated gastric juice. Furthermore, the increase in viable
counts of bacteria could be attributed to the addition of prebiotic. Alginate and prebiotics
such as inulin or oligosaccharides tend to be synergistic in gelling and as a result it may
help to maintain and improve the degree of protection to bacterial cells (Capela 2006).
43
Figure 4.6: Survival of free and microencapsulated (A) Lactobacillus acidophilus and
(B) Lactobacillus casei in simulated gastric juice.
4.4. c. Survival of free and microencapsulated bacteria in simulated intestinal juice
The effect of the simulated intestinal juice on the viability of the microencapsulated
and free probiotic bacteria after treatment with simulated gastric juice is presented in
Figure 4.7. The number of free probiotics was found to be decreased significantly as the
incubation time increased. The result indicated that alginate-gelatin microcapsules with
lactulose as prebiotic was most effective in survival of L.acidophilus in simulated
intestinal juice with an encapsulation efficiency of 97.38 % followed by inulin
encapsulated alginate beads(97.18%). This substantiate the possibility that prebiotics have
some effect on encapsulation efficiency. Similarly when L.casei after exposure to SGJ for
2 hours when introduced to SIJ, number of free cells found to be decreased drastically with
a viability of only 3.6 %. While, alginate encapsulated with lactulose showed maximum
survival (85.9 %).This is in good agreement with the results of Krasaekoopt et al in 2004
who indicated that the survival of probiotic bacteria was highly enhanced in gastro-
0
1
2
3
4
5
6
7
8
9
10
0 H 1 H 2 H
surv
iab
iliy
(lo
g C
FU/g
m)
Time(hours)
(A)
Free cells L.acidophilus
lact.+ Alg.
inl+Alg
L.A+alg
LA +Alg.gel
LA +Alg.gel+ lact.
LA +Alg.gel+inl.
0
1
2
3
4
5
6
7
8
9
10
0 H 1 H 2 H
surv
iab
iliy
(lo
g C
FU/g
m)
Time(hours)
(B)
Free cells L.casei
LC+lact.+ Alg.
LC+inl+Alg
L.c+alg
Lc +Alg.gel
Lc +Alg.gel+ lact.
Lc +Alg.gel+inl.
44
intestinal conditions when encapsulated with alginate-chitosan or poly-L-lysine. For
L.acidophilus, additional coating of sodium alginate with gelatin found to provide better
survival in simulated gastrointestinal condition, but for L.casei, gelatin was found to confer
no additional protection than alginate.
Figure 4.7: Survival of free and microencapsulated (A) Lactobacillus acidophilus and
(B) Lactobacillus casei in simulated intestinal juice.
4.5. Co-encapsulated synbiotic yogurt
Synbiotic yogurt were prepared by inoculating free, and co-encapsulated Probiotic
cultures (Lactobacillus acidophilus and Lactobacillus casei) with prebiotics (inulin and
lactulose). The acidification profile was recorded hourly until a pH of 4.7-4.5 was reached.
Fermentation was stopped by sudden cooling of the yogurt and stored at 40 C for 28 days.
Physicochemical properties (pH, titratable acidity, syneresis) and viability of probiotic
bacteria in both sample were evaluated at every 7 day interval for a period of 28-days.
0
1
2
3
4
5
6
7
8
9
3 H 4 H 5H 6H
surv
iab
iliy
(lo
g C
FU/g
m)
Time(hours)
(A)Free cellsL.acidophilus
lact.+ Alg.
inl+Alg
L.A+alg
LA +Alg.gel
LA +Alg.gel+lact.
LA +Alg.gel+inl.
0
1
2
3
4
5
6
7
8
3 H 4 H 5H 6H
surv
iab
iliy
(lo
g C
FU/g
m)
Time(hours)
(B)Free cellsL.casei
LC+lact.+ Alg.
LC+inl+Alg
L.c+alg
Lc +Alg.gel
Lc +Alg.gel+lact.
Lc+Alg.gel+inl.
45
4.5. a. pH changes during storage
The pH changes of co-encapsulated synbiotic yogurt (Lactobacillus acidophilus
and Lactobacillus casei) during storage at 4°C at every 7 day intervals for a period of 28
days are shown in Figure 4.8.
Figure 4.8: The pH changes of co-encapsulated symbiotic yogurt (A) Lactobacillus
acidophilus and (B) Lactobacillus casei during storage at 4°C for a period of 28 days.
The pH changes of co-encapsulated synbiotic yogurt during storage was found to
be lesser than the yogurt inoculated with free probiotic bacteria. The synbiotic yogurt
3.8
3.9
4
4.1
4.2
4.3
4.4
4.5
4.6
4.7
Day(0) Day 7 Day 14 Day 21 Day 28
pH
Days of storage
L. acidophilus
Control
inulin+alg
inulin+alg+gel
lactulose+alg
lactulose+alg+gel
3.8
4
4.2
4.4
4.6
4.8
Day(0) Day 7 Day 14 Day 21 Day 28
pH
Days of storage
L. casei
Control
inulin+alg
inulin+alg+gel
lactulose+alg
lactulose+alg+gel
46
containing encapsulated cells with alginate – gelatin in both of L.casei and L.acidophilus
samples showed the minimum of pH changes during storage times. Decrease in pH of
synbiotic yogurt samples containing free states of L.acidophilus was about 0.6 units and
in samples containing encapsulated bacterial cells with inulin in alginate and in alginate-
gelatin were about 0.25 and 0.23 unit respectively. But for lactulose the difference were
0.33 and 0.27 unit respectively. For L.acidophilus least change in pH was shown by inulin
encapsulated in alginate- gelatin mixture than control and alginate beads. Free cells of
L.casei inoculated in synbiotic yogurt samples was found to decreased the pH of about
0.58 units and bacterial cells with inulin encapsulated with alginate and alginate – gelatin
were decreased the pH of their environments about 0.39 and 0.4 units respectively and
with lactulose these difference were 0.29 and 0.28 units respectively. Lactulose
encapsulated in gelatin alginate was found to have significant effect on producing least
change in pH. There was significant difference (P<0.05) in pH during storage between
alginate and alginate gelatin encapsulated forms with both prebiotic for L.acidophilus and
L.casei.
4.5. b. Producing acidity during storage
Measuring the acidity at every 7- day intervals observed similar result as that of
pH for a period of 28 days of storage at 4°C. Accordingly an increase in acidity in samples
containing free L.acidophilus was approximately 0.53 %and an in increase in acidity in
samples containing encapsulated cells in alginate and alginate - gelatin with inulin were
found to be 0.34 % and 0.2 % respectively and with lactulose it was 0.31% and 0.3 %
respectively. All the treatment differ significantly from that of control with inulin in
alginate-gelatin showed least difference. For L.casei all the treatment differ significantly
from control but the microencapsulation with lactulose showed a significant difference
between alginate and alginate gelatin.
47
Figure 4.9: Percentage of acidity in microencapsulated synbiotic yogurt - Lactobacillus
acidophilus and Lactobacillus casei - storage at 4°C for a period of 28 days.
As a result, increase in acidity during storage until 28 days in sample containing
encapsulated probiotic cells were less than that of free states for both L.acidophilus and
L.casei. Therefore, microencapsulation of free cells, restricted their metabolic activity
greatly, but not completely [ISIRI number 5222 (2000)].
0.6
0.7
0.8
0.9
1
1.1
1.2
1.3
1.4
1.5
Day(0) Day 7 Day14 Day 21 Day 28
Titr
atab
le a
cid
ity(
% L
acti
c ac
id)
Days of storage
L. acidophilus
Control
inulin+alg
inulin+alg+gel
lactulose+alg
lactulose+alg+gel
0.6
0.7
0.8
0.9
1
1.1
1.2
1.3
1.4
1.5
Day(0) Day 7 Day 14 Day 21 Day 28Titr
atab
le a
cid
ity(
% L
acti
c ac
id)
Days of storage
L. casei Control
inulin+alg
inulin+alg+gel
lactulose+alg
lactulose+alg+gel
48
4.5. c. Syneresis on storage
Syneresis of microencapsulated synbiotic yogurt (Lactobacillus acidophilus and
Lactobacillus casei) during storage at 4°C at every 7-day interval for a period of 28 days
was shown in Figure 4.10. For L.acidophilus, syneresis on microencapsulation with inulin
in alginate gelatin beads showed least difference after 28 days of storage (2.7 %) compared
to inulin - alginate (3.2%) and that of control (10.6%). Microencapsulated yogurt with
lactulose in alginate and alginate - gelatin showed a difference in syneresis of 5% and 4%
respectively. So inulin in alginate –gelatin mixture showed a least difference in syneresis
(p<0.05) than other samples. For L.casei syneresis of microencapsulation with inulin in
alginate gelatin beads showed least difference during 28 days of storage (3.5 %) compared
to inulin -alginate (3.8%) and that of control (10.6%). Microencapsulated yogurt with
lactulose in alginate – gelatin and alginate showed a difference in syneresis of 3% and
3.3% respectively. So lactulose in alginate – gelatin mixture showed a least difference in
syneresis (p<0.05) than other samples.
49
Figure 4.10: Synersis of co-encapsulated synbiotic yogurt - Lactobacillus acidophilus and
Lactobacillus casei - during storage at 4°C for a period of 28 days
15
20
25
30
35
40
45
Day(0) Day 7 Day14 Day 21 Day 28
syn
eres
is %
Days of storage
L.acidophilus
Control
inulin+alg
inulin+alg+gel
lactulose+alg
lactulose+alg+gel
15
20
25
30
35
40
45
Day(0) Day 7 Day 14 Day 21 Day 28
syn
eres
is %
days of storage
L.casei
Control
inulin+alg
inulin+alg+gel
lactulose+alg
lactulose+alg+gel
50
4.5. d. Viability of Lactobacillus strains grown in microencapsulated synbiotic
yogurt
4.5. d.I Survival of free and microencapsulated synbiotic L.acidophilus in Yogurt
during storage time
The effect of encapsulation with Gelatin and alginate mixtures (2%) and that of
alginate on the viability of probiotic microorganisms in the Yogurt during 28 days of
refrigerated storage period (4°C) was investigated. Logarithmic numbers of surviving
bacteria (log cfu/gm) were measured at every seven-day intervals were shown in the
Table 4.6.
Table 4.6: Logarithmic numbers of surviving bacteria (log cfu/gm) at seven-day intervals
for 28 days.
Viable count (log cfu/gm) of L.acidophilus
Day(0) Day 7 Day14 Day 21 Day 28
Control 8.59 7.3 6.98 6.61 5.81
inulin+alginate 8.37 9.28 8.12 7.67 6.84
inulin+alginate+gelatin 8.44 9.34 8.28 8.12 7.2
lactulose+alginate 8.28 8.93 8.65 7.28 6.6
lactulose+alginate+gelatin 8.4 9.34 8.98 7.92 6.81
There was a decline of about 2.78 logs over a period of 4 weeks in the cell numbers
of strains of L.acidophilus when present as free cultures, whereas there was only a 1.53
and 1.24 -log cycle decrease in cell numbers with inulin co-encapsulated in alginate and
alginate – gelatin mixture respectively. When the same organism were encapsulated with
Lactulose (1%) and alginate (2% concentration) showed a decrease of 1.68 logs, while the
encapsulated state with Lactulose and alginate – gelatin showed a decrease of 1.59 logs.
51
Therefore decrease in viable count of L.acidophilus significantly differ (p<0.05) from that
of control sample in both treatment with inulin and lactulose as prebiotic with inulin and
alginate - gelatin showed least reduction in viable cells. Mean viable count of
L.acidophilus was decreased below 7.00 log CFU/gm after treatment except inulin
encapsulated in alginate –gelatin mixture (7.2 log CFU/gm).Therefore this treatment can
be used to confer therapeutic benefit after refrigerated storage.
4.5. d.II. Survival of free and microencapsulated symbiotic L.casei in Yogurt during
storage
Viable cells of L.casei in yogurt during 28 days of storage was shown in table 4.7.
In the case of free L.casei, the cell numbers lowered substantially about 2.8 log numbers
during 28 days of storage at 4°C, however the decrease of the viable counts of
encapsulated bacteria in alginate and alginate-gelatin with inulin were 1.35 log and 1.34
log respectively and with lactulose 1.02 logs only, for both types of beads. There was a
significant difference (P<0.05) observed between mean counts of viable cells during
storage time (28 days) in free states of L.casei and both of encapsulated samples. However
there was no significant difference observed in mean viable cells during storage time
between gelatin alginate and alginate encapsulated forms. However mean viable count of
L.casei was maintained above 107 CFU /gm in all treatment to provide therapeutic benefit
in which least reduction was shown by encapsulation with lactulose. These results
indicated increase in viability and resistance of probiotic cells by encapsulation against
harsh environmental conditions at storage times.
52
Table 4.7: Logarithmic number of surviving L.casei on storage at 7 day interval for
28 days.
Viable count (log CFU/gm) of L.casei.
Day(0) Day 7 Day 14 Day 21 Day 28
Control 8.6 7.57 6.65 6.31 5.8
inulin+alginate 8.8 8.65 8.61 8.55 7.45
inulin+alginate+gelatin 8.85 8.73 8.67 8.58 7.51
lactulose+alginate 8.7 8.71 8.67 8.31 7.68
lactulose+alginate+gelatin 8.67 8.64 8.61 8.0 7.65
The presence of lactic acid combined with the low pH of yogurt might be
responsible for the low viability of free probiotic cultures in yogurt. There was a significant
increase (P < 0.05) in the viable counts of L .acidophilus in inulin coated co-encapsulated
alginate gelatin beads compared with the alginate encapsulated and free cells. Survival of
probiotics in alginate-starch beads (in the size range of 1.0 mm) was improved during
refrigerated storage in yogurt (Sultana and others 2000). It was shown that the positive
role of incorporation of prebiotic (inulin) into the alginate mix during encapsulation.
Likewise for L.casei there was a significant difference (P<0.05) between mean counts of
viable cells of both of encapsulated samples when Lactulose was used as prebiotic, but
showed no significant difference between alginate and alginate – gelatin mixture.
53
Figure 4.11: Survival of free, and co-encapsulated bacteria (L. acidophilus and L. casei)
in yogurt over a shelf life period of 4 weeks.
Sultana et al., [2000] showed that using the Hi maize in encapsulation of probiotics
can significantly improved protection of viable bacterial counts in synbiotic ice cream and
Iranian white brined cheese. Increasing cell stability of encapsulated probiotic bacteria
with calcium alginate over the refrigerated storage time has been previously reported by
Krasaekoopt, Kailasapathy and Mortazavianetal 2008, that are in agreement with the
5
5.5
6
6.5
7
7.5
8
8.5
9
9.5
10
Day(0) Day 7 Day14 Day 21 Day 28
Log
(C
FU/g
m)
Days of storage
L.acidophilus Control
inulin+alg
inulin+alg+gel
lactulose+alg
lactulose+alg+gel
5
5.5
6
6.5
7
7.5
8
8.5
9
9.5
10
Day(0) Day 7 Day 14 Day 21 Day 28
Log
(CFU
/gm
)
Days of storage
L.casei
Control
inulin+alg
inulin+alg+gel
lactulose+alg
lactulose+alg+gel
54
results obtained from present research. Also these data again confirmed advantages of
encapsulation of probiotic cells with gelatin in combination with alginate that give more
protection of viable counts of L.acidophilus compared free state caused. In addition, it was
demonstrated that, encapsulated cells required longer time to decrease one log cycle in
viable counts and encapsulated L. acidophilus with alginate gelatin and inulin as prebiotic
had the most slow rate of loss of viable cell rate. Overall the problem of sensitivity to
acidity of the probiotic culture is compounded by the fact that acidity may increase during
storage, a phenomenon known as ‘over acidification’ [Adeli et al, 2010]. Increasing rate
of viability decline of free probiotic bacteria can be attributed to the adverse effects of
accumulated organic acid by L.acidophilus and L.casei, but encapsulated bacteria
accumulating organic acid and hydrogen ions at a lower rate because of limitation
accessibility to nutrients. This fact is indicated by slower rates of pH drop and acidity
increase during refrigeration of both encapsulated types of probiotic bacteria which caused
a slower rate of viability decline compared to free probiotic bacteria cells. But the greater
loss of survival of encapsulated L.acidophilus and L.casei cells at the end of storage period
may be due to the gradual increase in the amount of organic acid molecules inside the
capsules after slow diffusion through the capsules pores. In this regard, reduction of
metabolic activity of probiotic cells in the case of coated cells with gelatin and alginate
caused a very gentle increase of acidity and so slow loss of viable cells during refrigeration
period .With comparing two strains of probiotic cells, it was found that loss of all types of
free and coated bacterial cells of L.casei from initial day to 28th day was lower than
L.acidophilus cells. In this way the survival of bacteria against unfavourable conditions
could be species dependent. This finding is in agreement with those of Haynes, 2002 and
Kailasapathy 2005.
55
According to the results obtained, microencapsulation with alginate gelatin and
inulin found to have the best efficiency to survival of L.acidophilus, while Lactulose
encapsulated in alginate/alginate-gelatin provide best protection of L.casei during
refrigerated storage, enough for therapeutic effects. Different studies have shown that
calcium alginate microcapsules are better protected in the presence of prebiotics (Sultana
et al 2000, Chen et al 2005).Adding encapsulated LAB can slower post acidification and
also reduces acid development in yoghurt during storage. Overall sensory aspects in
yoghurt do not substantially alter when encapsulated bacteria are incorporated, and
survival of probiotics during storage can be improved by microencapsulation technique
(Kailasapathy, 2006). Using calcium alginate for the microencapsulation of probiotic
bacteria in combination with prebiotics (e.g., inulin and Lactulose) in yoghurt, viability
and survivability of encapsulated cells can be improved due to reduced acid production of
LAB during storage (Sultana et al., 2000).
56
Chapter 5
CONCLUSION
The synbiotic functional food approach offers an additional health benefit by
providing probiotics and prebiotics. The growth, activity and viability of Lactobacillus
strains in RSM were dependent on prebiotics as well as strain. Physicochemical and
microbiological properties of probiotic and synbiotic yogurt were evaluated in the first day
and thereafter every 7 days interval for four weeks on refrigerated storage at 40C. During
cold storage, pH, and probiotic bacterial count decreased, while acidity and syneresis were
increased in Probiotic yogurt prepared with both organisms. Neither Inulin nor Lactulose
had significant effect on physicochemical properties (except pH) and probiotic bacterial
survival of L.acidophilus. There was a significant decrease (p<0.05) in pH of synbiotic
yogurt with inulin and lactulose. For L.casei, both prebiotics had significantly reduced pH
and increased acidity, and found to have some effect on viability of probiotic bacteria, but
inulin produced least change in syneresis.
Amongst the various approaches, microencapsulation has emerged as the best
alternative so as to overcome the problem of poor survivability of probiotic cultures in the
food matrix as well as in the gastrointestinal environment. Microencapsulation of
L.acidophilus and L.casei in calcium alginate and calcium alginate-gelatin resulted in
better in vitro release and survival of cells in simulated gastro-intestinal condition (along
with pepsin and bile salt), compared to free cells. Prebiotic addition were found to provide
better survival of both probiotic for gastro-intestinal condition. Therefore the applied
approach in this study might prove beneficial for the delivery of probiotic cultures to the
human gastro-intestinal tract. Of the six types of microcapsules with prebiotic in this
research, microencapsulated lactulose provided the best protection and survival of
57
L.acidophilus and L.casei cells in simulated gastro-intestinal condition. Survival of free
L.acidophilus and L.casei drastically decreased due to its low acid and bile resistance.
The concept of co-encapsulation offers the potential for increased efficacy of
functional foods by exploiting the synergy between prebiotic and probiotic ingredients.
According to the results of this study, microencapsulation of Probiotic bacterial cells with
alginate–gelatin with inulin showed significant (p<0.05) effect on least change in pH,
acidity, bacterial count and syneresis of L.acidophilus, while alginate–gelatin with
lactulose showed significant (p<0.05) effect on least change in physicochemical and
microbiological properties of L.casei. The final results showed that L.casei had a higher
viability than the level of the therapeutic minimum (>107 CFU/g) after 28 days of storage
in all the treatment while for L.acidophilus, only inulin encapsulated in alginate–gelatin
maintained the count above this limit. So co-encapsulation of synbiotics can be used to
enhance and improve the physicochemical properties and viability of probiotic bacteria
during processing and also in gastrointestinal tract.
Future studies need to monitor the efficacy of co-encapsulated bacteria in the gut,
using animal models. Also, the sensory evaluation of yogurt with microencapsulated
prebiotics and probiotic bacteria will reveal the consumer response to the texture and the
changes in organoleptic characteristics of the yogurt.
58
BIBLIOGRAPHY
1. Adelimilani M, Mizani M, Gavami M (2010). Effects of yellow mustard powderon
microbial population, pH and organoleptic properties of mayonnaise. Iranian Journal
of Nutrition Sciences & Food Technology 5: 35-44.
2. Adhikari K, Mustapha A, Grun I U and Fernando L (2000). Viability of micro
encapsulated bifidobacteriain set yogurt during refrigerated storage. J. Dairy Sci., 83:
1946-1951.
3. Adhikari, K, Mustapha A, Grun I U (2003).Survival and metabolic activity of
microencapsulated bifidobacteriumlongum in stirred yogurt. Journal of Food Science
68(1) 275-280.
4. Anal AK, Singh H (2007) “Recent advances in microencapsulation of probiotics for
industrial applications and targeted delivery” Trends Food SciTechnol, 18: 240-251.
5. AOAC (2002). Official Methods of Analysis of the AOAC, 15th Edn. (ed.
S.williams) Association of Official Analytical Chemists, Arlington.
6. Aragon-Alegro, L., Alarcon Alegro, JH, Roberta Cardarelli H, Chih Chiu M, and
IsaySaad, SM (2007). Potentially probiotic and synbiotic chocolate mousse LWT-
Food Sci. Technol.; 40:669–675.
7. Berrada, N, Lemeland JF, Laroche G, Thovenot P and Piaia M (1991). Bifidobactrium
from fermented milk: Survival during gastic transit. J Dairy Sci; 74: 409
8. Brinques GB, Ayub MAZ (2011). Effect of microencapsulation on survival of
Lactobacillus plantarum in simulated gastrointestinal conditions, refrigeration, and
yogurt. J. Food Eng.; 103:123–128.
9. Burgain C, Gaiani M, Linder, and Scher J (2011). “Encapsulation of probiotic living
cells: From laboratory scale to industrial applications” J.Food Eng, 104: 467-483.
59
10. Capela P, Hay TKC, and Shah NP (2006). Effect of cryoprotectants, prebiotics and
microencapsulation on survival of probiotic organisms in yoghurt and freeze-dried
yoghurt. Food Res. Int;39:203–211
11. Champagne C P and Gardener N J (2005). Challenges in the Addition of Probiotic
Cultures to Foods. Critical Reviews in Food Science and Nutrition. 45:61-84.
12. Chandramouli V, Kailasapathy K, Peiris P and Jones M (2004). An improved method
of micro encapsulation and its evaluation to protect Lactobacillus spp. In simulated
gastric conditions. J. Microbiol. Meth., 56(1): 27-35.
13. Chávarri M (2010). Microencapsulation of a probiotic and prebiotic in alginate-
chitosan capsules improves survival in simulated gastro-intestinal conditions.
International Journal of Food Microbiology, v.142, p.185-189.
14. Chen KN, Chen MJ, Liu JR, Lin CW and Chiu HY (2005). Optimization of
incorporated prebiotics as coating materials for probiotic microencapsulation.
Journal Food Science 70 260-266.
15. Clark, PA and Martin JH (1993).Selection of Bifidobacteria for use as dietary
adjuncts in cultured dairy foods: III .Tolerance to simulated bile of human stomachs.
Cult. Dairy Prod. J;29: 18-21
16. Collins M D, G R Gibson (1999). Probiotics, prebiotics, and synbiotics: approaches
for modulating the microbial ecology of the gut. Am. J. Clin. Nutr. 69:1052S-1057S.
17. Cook MT and Tzortzis G (2012). “Microencapsulation of probiotics for
gastrointestinal delivery” J Control Releas., 162: 56-67.
18. Corcoran BM and Ross RP (2004). “Comparative survival of probiotic lactobacilli
spray-dried in the presence of prebiotic substances” J Appl Microbiol, 96: 1024-1039.
60
19. Coussement P. (1996). Pre- and synbiotics with inulin and oligofructose: promising
developments in functional foods. European Food Research and Technology 102-
104.
20. Cummings JH, Christie S. and Cole TJ (2001). A study of fructo oligosaccharides in
the prevention of travellers’ diarrhoea. Alimentary Pharmacology Therapeutics,
15:1139- 1145
21. Dave IR and Shah NP (1997). Viability of Yoghurt and probiotic bacteria in Yoghurts
made from Commercial Starter Cultures. International Dairy Journal, 7:31-41.
22. Dave R I and Shah N P (1996). Effect of Level of Starter Culture on Viability of
Yoghurt and Probiotic Bacteria in Yoghurts. Food Australia, 49 (4) 164-168.
23. Dembczynski R and Jankowski T (2002). Growth characteristics and acidifying
activity of Lactobacillus rhamnosus in alginate/starch liquid-core capsules. Enzyme
Microb. Technol., 31(1-2): 111-115.
24. Ding WK and Shah NP (2009). Effect of various encapsulating materials on the
stability of probiotic bacteria. J. Food Sci., 74(2): M100-M107.
25. DiRienzo DB (2000). Symposium: Probiotic Bacteria: Implications for Human
Health. Journal of Nutrition, 130: 382S-383S.
26. Donthidi AR, Tester RF and Aidoo KE (2010). Effect of lecithin and starch on
alginate-encapsulated probiotic bacteria. J. Microencapsul.; 27:67–77.
27. FAO/WHO, Probiotics in food (2006). Health and nutritional properties and
guidelines for evaluation FAO Food and Nutrition Paper No. 85, World Health
Organization and Food and Agriculture Organization of the United Nations, Rome,
Italy. 1-50.
61
28. Fritzen-Freire CB and Prudêncio ES (2013).Effect of microencapsulation on survival
of BifidobacteriumBB-12 exposed to simulated gastrointestinal conditions and heat
treatments” LWT-Food SciTechnol, 50: 39-44.
29. Fritzen-Freire CB, ES Prudencio RD,MC Amboni, SS Pinto, AN Negrao-Murakami
and FS Murakami (2012). Microencapsulation of Bifidobacteria by spray drying in
the presence of prebiotics. Food Research International, 45, pp. 306–312.
30. Fuller R (1989). Probiotics in man and animals. A review. Journal of Applied
Bacteriology, 66, 365-378.
31. Fung WY, Yuen KH and Liong MT (2011). Agro-waste based nanofibers as a
probiotic encapsulant: Fabrication and characterization. J. Agr. Food Chem., 59(15):
8140-8147.
32. Gbassi GK, Vandamme T (2009). “Microencapsulation of Lactobacillus plantarum
spp. in an alginate matrix coated with whey proteins” Int J Food Microbiol, 129: 103-
33. Gibson G R, Beatty E B, Wang X and Cummings H (1995). Selective stimulation of
bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology (in
press) 108:975-982.
34. Gibson GR and Roberfroid MD (1995). Dietary modulation of the human colonic
microbiota – Introducing the concept of prebiotics. J.Nutr., 125:1401-1412.
35. Gibson GR, Berry Ottaway P and Rastall RA (2000). Prebiotics: New Developments
in Functional Foods. Chandos Publishing Ltd., Oxford.
36. Gilliland SE (1987). Importance of bile tolerence in lactobacilli used as dietary
adjunct.: In: Biotechnology in the feed industry. T. P. Lyons. Alltech Feed Co,
Lexington, KY: 149- 155.
37. Gill H and Prasad J (2008). “Probiotics, immunomodulation, and health benefits”
AdvExp Med Biol, 606: 423-454.
62
38. Goldin B R and Gorbach, S L (1984). The effect of milk and lactobacillus feeding on
human intestinal bacterial enzyme activity. American Journal of Clinical Nutrition,
39(5), p. 756-761.
39. Gomes A. and Malcata FX (1999). Bifidobacterium spp. and Lactobacillus
acidophilus biological, biochemical, technological and therapeutical properties
relevant for use as probiotics. Trends in Food Science and Technology, 10, 139–157
40. Gonzalez – Martinez C, Becerra M, Chafer M, Albors A, Carot JM. and Chiralt A.
(2002). Influence of substituting milk powder for whey powder on yoghurt quality.
Trends Food Science & Technology, 13,334-340.
41. Gouin S, (2004). “Microencapsulation-industrial appraisal of existing technologies
and trends” Trends Food SciTechnol, 15: 330-347.
42. Hammes W P and Vogel RF (1995). The genus Lactobacillus (Glasgow, Blackie
Academic & Professional).
43. Hansen LT, Allan-Wojtas PM, Jin YL.and Paulson AT (2002). Survival of Ca-
alginate microencapsulated Bifidobacterium spp in milk and simulated
gastrointestinal conditions. Food Microbiol.; 19:35–45.
44. Harnsilawat T and Pongsawatmanit R (2006). “Characterization of β-lactoglobulin-
sodium alginate interactions in aqueous solutions: a calorimetry, light scattering,
electrophoretic mobility and solubility study” Food Hydrocol, 20: 577-585.
45. Haynes IN and Playne MJ (2002). Survival of probiotic cultures in low fat ice cream.
Australian Journal of Dairy Technology 57: 10-14.
46. Heidebach T and Forst P (2009) “Microencapsulation of probiotic cells by means of
rennet-gelation of milk proteins” Food Hydrocol, 23: 1670-1677.
47. Hull RR, Roberts AV and Mayes J J (1984). Survival of Lactobacillus acidophilus in
Yoghurt. The Australian Journal of Dairy Technology, (12) 164-166.
63
48. ISIRI number 5222 (2000). Institute of Standards and Industrial Research of Iran.
Yoghurt – determination of total Titratable Acidity –Potentiometric method, Tehran,
Iran.
49. Kailasapathy K and Sultana K (2003). Survival and β-galactosidase activity of
encapsulated and free Lactobacillus acidophilus and Bifidobacteriumlactis in ice-
cream. Australian Journal of Dairy Technology 58 223-227.
50. Kailasapathy K, Masondole L (2005). Survival of free and microencapsulated
Lactobacillus acidophilus and Bifidobacterium lactis and the effect on texture of feta
cheese. Australian Journal of Dairy Technology 60: 252-258.
51. Kailasapathy K (2006). Survival of free and encapsulated probiotic bacteria and
effect on the sensory properties of yoghurt in LWT- Food Science and Technology
39(10):1221-1227.
52. Katz F (2001). Active Cultures Add function to Yogurt and Other Foods. Food
Technology, 55 (3) 46-49.
53. Kaur IP, Chopra K and Saini A (2002). Probiotics: Potential pharmaceutical
applications. Eur. J. Pharm. Sci., 15(1): 1-9.
54. Khalida S, Godward G, Reynolds N, Arumugaswamy R, Peiris P and Kailasapathy,
K (2000). Encapsulation of probiotic bacteria with alginate-starch and evaluation of
survival in simulated gastro-intestinal conditions and in yoghurt. Int. Food Microbiol.
62: 47-55.
55. Kim SJ, Cho SY, Kim SH, Song OJ, Shin IS, Cha DS and Park HJ (2008). Effect of
micro encapsulation on viability and other characteristics in Lactobacillus
acidophilus ATCC 43121. LWT-Food Sci. Technol., 41(2): 493-500.
56. Kopp-Hoolihan L (2001). Prophylactic and therapeutic uses of probiotics: A review.
J. Am. Diet. Assoc., 101(2): 229-241.
64
57. Krasaekoopt W, Bhandari B and Deeth H (2003). Evaluation of encapsulation
techniques of probiotics for yoghurt. International Dairy Journal 13, 3-13.
58. Krasaekoopt W, Bhandari B, Deeth H (2004) The influence of coating materials on
some properties of alginate beads and survivability of microencapsulated probiotic
bacteria. International Dairy Journal 14: 737-743.
59. Lankaputhra WEV and Shah NP (1995). Survival of Lactobacillus acidophilus and
Bifidobacterium spp in the presence of acid and bile salts. Cult. Dairy Prod. J., 30: 2-7.
60. Lee JS, Cha DS and Park HJ (2004). Survival of freeze dried Lactobacillus
bulgaricus KFRI 673 in chitosan coated calcium alginate microparticles. J. Agr.
FoodChem., 52(24): 7300-7305.
61. Lee WJ and Lucey J A (2004). Structure and Physical properties of Yogurt Gels:
Effect of Inoculation Rate and Incubation Temperature. Journal of Dairy Science
87:3153-3164.
62. Lilly DM and Still well. R H 1965). Probiotics: growth-promoting factors produced
by microorganisms. Sci. 147:747-748.
63. Ma Y, Xing Y, Wang T, Xu Q, Cai Y, Che Z, Wang Q and Jiang L (2014).
Microbiological and Other Characteristics of Micro encapsulation Containing
Lactobacillus acidophilus (CICC 6075). J. Pure Appl. Microbiol., 8(2): 1693-1699.
64. Mandal S and Puniya AK, (2006). “Effect of alginate concentrations on survival of
microencapsulated Lactobacillus casei NCDC-298” Int Dairy J, 16: 1190-1195.
65. Mandal SS, Hati AK, Puniya R. and Singh K. (2012). “Development of symbiotic milk
chocolate using encapsulated Lactobacillus casei NCDC 298,” Journal of Food
Processing and Preservation. 37 (5), 1031-1037.
66. Marteau P and Rambaud JC (1993). Potential of using lactic acid bacteria for therapy
and immunomodulation in man. FEMS Microbiol. Rev. 12: 207–220.
65
67. Marteau P and Seksik P (2002). “Probiotics and intestinal health effects: a clinical
perspective” Br J Nutr, (Suppl. S1), 88: S51-S57.
68. Mckinley MC (2005). The nutrition and health benefits of yoghurt. International
Journal of Dairy Technology, 58 (1) 1-12.
69. Michida H, Tamalampudi S, Pandiella SS, Webb C, Fukuda H and Kondo A (2006).
Effect of cereal extracts and cereal fiber on viability of Lactobacillus plantarum under
gastrointestinal tract conditions. Biochem. Eng. J.; 28:73–78.
70. Mladenovska K, Cruaud O (2007). “5-ASA loaded chitosan-Ca-alginate microparticles:
Preparation and physicochemical characterization” Int J Pharm, b, 345:59-69.
71. Mokarram RR, Mortazavi SA, Najafi MBH and Shahidi F (2009). The influence of
multi stage alginate coating on survivability of potential probiotic bacteria in
simulated gastric and intestinal juice. Food Res. Int.; 42:1040–1045.
72. Mortazavian AM, Ehsani MR, Azizi A, Razavi SH and Mousavi SM,(2008). Effect
of microencapsulation of probiotic bacteria with calcium alginate on cell stability
during the refrigerated storage period in the Iranian yogurt drink (Doogh). MILCAD
63: 233-348.
73. Nag A, Han KS and Singh H (2011). Micro encapsulation of probiotic bacteria using
pH-induced gelation of sodium caseinate and gellan gum. Int. Dairy J., 21:247-253.
74. Ortakci and S. Sert V (2012). “Stability of free and encapsulated Lactobacillus
acidophilus ATCC, 4356 in yogurt and in an artificial human gastric digestion
system,” Journal of Dairy Science, vol. 95, no. 12, pp. 6918–6925.
75. Ouwehand A C and Salminen S J (1998). The health effects of cultured milk products
with viable and non viable bacteria. Int. Dairy J., 8(9): 749-758.
76. Parkerr.B (1974).Probiotics: the other half of the antibiotic tory. Animal Nutrition
and Health, December, 4-8.
66
77. Pedroso D L, Thomazini M and Heinemann R J (2012). Protection of Bifidobacterium
lactis and Lactobacillus acidophilus by micro encapsulation using spray-chilling. Int.
Dairy J., 26(2): 127-132.
78. Petreska Ivanovska, Т, Petrushevska-Tozi, L, Grozdanov A, Petkovska R, Hadjieva
J, Popovski E, Stafilov T, Mla-denovska K ( 2014). From optimization of symbiotic
microparticles prepared by spray-drying to development of new functional carrot
juice. Chem. Ind. Chem. Eng. Quart. 20(4), 549-564.
79. Petrovic T and Nedovic V (2007) “Protection of probiotic microorganisms by
microencapsulation” ChemInd Chem Eng Quart, 13: 169-174.
80. Picot A and Lacroix C (2004). “Encapsulation of bifidobacteria in whey protein-
based microcapsules and survival in simulated gastrointestinal conditions and in
yoghurt” Int Dairy J., 14: 505-515.
81. Rao CV, M E Sanders, C Indranie, B Simi, and BS Reddy (1999). Prevention of
colonic pre neoplastic lesions by the probiotic Lactobacillus acidophilus NCFM in
F344rats. International Journal of Oncology, 14:939-944.
82. Reid G, Jass J, Sebulsky MT and McCormick JK (2003). Potential uses of Probiotics
in clinical practice. Clin. Microbiol. Rev., 16: 658-672.
83. Roberfroid M, Gibson GR and Delzenne N (1993) The biochemistry of oligofructose,
a non-digestible fiber: an approach to calculate its caloric value. Nutrition Reviews
51, 137-146.
84. Roberfroid MB, Van Loo J and Gibson GR (1998). The bifidogenic nature of chicory
inulin and its hydrolysis products. Journal of Nutrition 128(1):11-19.
85. Semyonov D, Ramon O, Kaplun Z, Levin-Brener L, Gurevich N and Shimoni E
(2010). Micro encapsulation of Lactobacillus paracasei by spray freeze drying. Food
Res. Int., 43: 193-202.
67
86. Shah NP (2000). Probiotic bacteria: Selective enumeration and survival in dairy
foods. J. Dairy Sci., 83: 894-907.
87. Shah NP and Ravula RR (2000). Microencapsulation of probiotic bacteria and their
survival in frozen fermented dairy desserts. Australian Journal of Dairy Technology
55 139-144.
88. Smilkov K and Petreska Ivanovska T (2013). “Optimization of the formulation for
the preparing of Lactobacillus casei loaded whey-protein-Ca-alginate microparticles
using full-factorial design” J Microencapsul, 1-10.
89. Soukoulis C, Yonekura L, Gan HH, Behboudi-Jobbehdar S, Parmenter C, Fisk
I(2014). Probiotic edible films as a new strategy for developing functional bakery
products: The case of pan bread. Food Hydrocolloids.; 39:231–242.
90. Sultana K, Godward G, Reynolds N, Arumugaswamy R, Peiris P and Kailasapathy
K. (2000). Encapsulation of probiotic bacteria with alginate-starch and evaluation of
survival in simulated gastro-intestinal conditions and in yoghurt. Int J Food
Microbiol. 62:47–55.
91. Suzuki K, Endo Y, Uehara M, Yamada H, Goto S, Imamura M and Shioza S (1985)
Effect of lactose, lactulose and sorbital on mineral utilisation and intestinal flora. J.
Jpn. Soc. Nutr. Food Sci. 38: 39 – 42.
92. Tharmaraj N and Shah NP (2003). Selective enumeration of Lactobacillus delbrueckii
ssp. bulgaricus, Streptococcus thermophilus, Lactobacillus acidophilus, bifidobacteria,
Lactobacillus casei, Lactobacillus rhamnosus, and propionic bacteria. J Dairy
Sci.;86:2288–2296
93. Tamura Z (1983).Nutriology of bifidobacteria. Bifid. Microflora 2: 3–16.
68
94. Terada A, Hara H, Kataoka M and Mitsuoka T (1992): Effect of lactulose on
composition and metabolic activity of the human faecal flora. Microb. Ecol. Health
Dis. 5, 43–50.
95. Wang X and Gibson G R (1993). Effects of the in vitro fermentation of oligofructose
and inulin by bacteria growing in the human large intestine. Journal of Applied
Bacteriology 75: 373-380.
96. Woo C, Lee K and Heo T (1999). Improvement of Bifidobacterium longum stability
using cell-entrapment technique. J. Microbiol. Biotechnol.; 9:132–139.
97. Yu WK, Yim TB, Lee KY and Heo TR (2001). Effect of skim milk-alginate beads
on survival rate of bifidobacteria. Biotechnol. Bioprocess Eng.; 6:133–138.
98. Xing Y, Xu Q, Ma Y, Che Z, Cai Y and Jiang L (2014).Effect of porous starch
concentrations on the microbiological characteristics of micro encapsulated
Lactobacillus acidophilus. Food Funct., 5(5): 972-983.